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ACRONYMS 
 
ANOVA = Analysis of Variance 
ASI = Anxiety Sensitivity Index 
BDI = Beck Depression Inventory 
BH = Breath-holding 
BT = Breathing Training 
CBT = Cognitive-Behavioral Therapy 
CO2 = Carbon Dioxide 
ECG = Electrocardiogram  
EDA = Electrodermal Activity 
ES = Effect Size 
GAD = Generalized Anxiety Disorder 
HYPO = Hypoventilation  
HR = Heart Rate 
HV = Hyperventilation 
DSM = Diagnostic and Statistical Manual 
MV = Minute Ventilation 
NAC = Non-anxious Controls 
NSF = Non-specific Fluctuations 
OCD = Obsessive-Compulsive Disorder 
pCO2 = Partial Pressure of Arterial Blood Carbon Dioxide 
PD = Panic Disorder 
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RR = Respiration Rate 
RRI = Respiratory Rate Instability 
RSATF = Respiratory Sinus Arrhythmia (transfer function) 
SCL = Skin Conductance Level 
SOP = Social Phobia 
VT = Tidal Volume 
VTI = Tidal Volume Instability 
VHO = Voluntary Hypoventilation Test 
VHT = Voluntary Hyperventilation Test 
WL = Waiting List 
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SUMMARY 
 
Panic Disorder (PD) has been associated with abnormalities in the respiratory 
system for a long time, and treatment programs aimed at reversing these abnormalities 
have been developed. Panicogenic effects of biological challenges have been shown to be 
altered after successful treatment. Furthermore, there is evidence that anxious non-PD 
patients show similar responses to these challenges and hence may benefit from some 
kind of breathing training (BT).  
 
To test these assumptions, we recruited 45 PD patients, 39 Episodic Anxiety (EA) 
patients who suffered from subclinical panic attacks, and 20 non-anxious controls (NAC). 
Patients were randomized to one of two versions of a 4-week therapy with BT, either 
lower or raise end-tidal pCO2, or a waiting list (WL). Before and after treatment, 
participants underwent in randomized order a Voluntary Hypoventilation (VHO) test and 
a Voluntary Hyperventilation (VHT) test in which they were asked to either lower or 
raise their pCO2 while psychophysiological measures were recorded. Each test consisted 
of 3 segments: 1 min baseline, 3 min paced breathing, and 8 min recovery.  
 
Before treatment, PD and EA patients were more anxious, distressed, tense, and 
worried than NAC, and felt more dizziness, chest pain, and nausea during the laboratory 
assessment. However, increases in psychological symptoms or physiological sensations 
from baseline to the paced breathing segments were not different between groups. The 
two tests produced similar changes except that anxiety and dizziness increased more 
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during the VHT than VHO. We replicated baseline breathing abnormalities previously 
reported for PD patients, namely greater respiration rate, tidal volume instability, and 
number of sighs. However, analyses did not find that patients recovered slower to either 
challenge. After treatment, both therapies improved on the main outcome measure. 
Furthermore, BT affected baseline pCO2, resulting in lower levels in the hypocapnic 
groups and higher levels in the hypercapnic groups without affecting any other measures.  
 
We conclude that baseline respiratory abnormalities are specific to PD. However, 
data suggest that the manipulations might have been too weak to elicit other previously 
reported group differences. Breathing training was equally effective for the lower and 
raise BT. Hence, factors unrelated to modifying one’s pCO2 must have accounted for the 
symptomatic improvement. Breathing training should not be restricted to PD but be 
applied to all patients suffering from anxiety attacks. 
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ZUSAMMENFASSUNG 
 
Panikstörung (PD) wird seit langer Zeit mit Abnormalitäten im Atmungssystem in 
Verbindung gebracht. Infolgedessen wurden Therapieprogramme entwickelt, die auf  
eine Normalisierung der Atmung abzielen. Studien zeigten, dass nach erfolgreichem 
Therapieabschluss die angstauslösenden Effekte von verschiedenen Atemstresstests 
vermindert waren. Weiterhin gibt es Hinweise, dass Angstpatienten, die nicht an 
Panikstörung leiden, ähnliche Reaktionen zeigen und demzufolge von einer Atemtherapie 
profitieren könnten. 
 
Um diese Annahmen zu überprüfen, wurden 45 Patienten mit Panikstörung, 39 
Patienten mit episodischen Angstattacken (EA) und 20 Kontrollpersonen rekrutiert. 
Patienten wurden in eine von zwei vierwöchigen Atemtherapien randomisiert, in denen 
die Verminderung oder Erhöhung des endexpiratorischen pCO2 Niveaus vermittelt 
wurde, bzw. eine Warteliste. Vor und nach der Therapie wurde bei allen 
Versuchspersonen ein instruierter Hypoventilations- (VHO) und Hyperventilationstest 
(VHT) durchgeführt. Die Versuchspersonen wurden gebeten, ihr pCO2 zu verringern oder 
zu erhöhen, während verschiedene psychophysiologische Parameter aufgezeichnet 
wurden. Beide Labortests bestanden aus drei Teilen: 1 Minute Basismessung, 3 Minuten 
kontrolliertes Atmen, 8 Minuten Erholungsphase.     
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Vor Beginn der Therapie waren Patienten beider Therapiebedingungen tonisch 
ängstlicher, gestresster, angespannter und beunruhigter als Kontrollpersonen. Zusätzlich 
empfanden sie mehr Schwindel, Brustschmerzen und Übelkeit. Allerdings waren die 
Veränderungen der psychophysiologischen Symptome während der Tests in allen 
Untersuchungsgruppen gleich. Die Analysen zeigten nur bei PD und nur während der 
Basismessung Abnormalitäten in der Atmung auf, und zwar höhere Atemfrequenz, 
Atemvolumeninstabilität, und Anzahl an Seufzern. Eine langsamere Erholung nach 
Hypo- oder Hyperventilation konnte jedoch nicht repliziert werden. Nach der Therapie 
zeigten alle PD und EA Patienten signifikante Verbesserung bezüglich des primären 
Messinstrumentes. Weiterhin wurde das tonische pCO2 Niveau durch die Therapie in der 
hypokapnischen Bedingung vermindert und in der hyperkapnischen erhöht.  
 
Wir schlussfolgern, dass Abnormalitäten im Atmungssystem unter 
Normalbedingungen spezifisch sind für PD. Andererseits waren unsere Labortests 
wahrscheinlich zu schwach, um die typischen Gruppenunterschiede während Hypo- und 
Hyperventilation aufzuzeigen. Die Effektivität beider Atemtherapien war vergleichbar. 
Demzufolge ist die symptomatische Verbesserung Faktoren zuzuschreiben, die nicht mit 
der direkten Beeinflussung des pCO2 Niveaus in Verbindung stehen. Die Behandlung mit 
Atemtherapie sollte nicht auf PD eingeschränkt, sondern auf  alle Patienten erweitert 
werden, die an Angstattacken leiden. 
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INTRODUCTION  
 
For a long time a link between respiration and emotion has been reported. The 
respiratory system in anxiety disorders in general, and in Panic Disorder (PD) in 
particular has come to the attention of researchers. Breathing abnormalities have been 
postulated as a central feature in the pathophysiology of PD. Evidence comes from 
studies in which breathing patterns at rest and psychophysiological effects of different 
biological challenges were investigated. Hyperventilation (HV), inhalation of carbon 
dioxide (CO2) gas mixtures, and breath holding, have been used to trigger panic, although 
their effects on respiration may be opposite, e.g., producing hypocapnia or hypercapnia. 
The importance of physiology for PD is also reflected in the criteria for panic attacks in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, American 
Psychiatric Association, 1994). They are a list of some psychological, but mostly 
physiological symptoms that indicate autonomic and respiratory dysregulation. 
 
 
Respiratory Abnormalities in Panic Disorder  
 
Baseline Differences 
Respiratory measures, particularly end-tidal pCO2 (partial pressure of CO2), and 
cardiac measures have been shown to distinguish between PD and comparison groups at 
rest. However, evidence for the existence of chronic HV in PD, as indicated by low 
pCO2, is mixed. Lower basal pCO2 levels have been found in several studies to 
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distinguish healthy volunteers from PD patients (Abelson, Weg, Nesse, & Curtis, 2001; 
Hegel & Ferguson, 1997; Papp et al., 1997; Roth, Wilhelm, & Trabert, 1998; Salkovskis, 
Jones, & Clark, 1986; Wilhelm, Trabert, & Roth, 2001; Woods et al., 1986) or from other 
anxiety disorders such as Generalized Anxiety Disorder (GAD) (Hegel & Ferguson, 
1997; Munjack, Brown, & McDowell, 1993; Rapee, 1986; Roth, Wilhelm, & Trabert, 
1998). Zandbergen and colleagues (Zandbergen, van Aalst, de Loof, Pols, & Griez, 1993) 
found lower pCO2 in PD compared to other anxiety disorders but not to non-anxious 
controls (NAC). On the other hand, van den Hout et al. (1992) also showed depressed 
pCO2 levels in non-PD anxiety disorders. The authors concluded that HV is not specific 
to PD. In fact, hypocapnia is sometimes absent in PD (de Ruiter, Ruken, Garssen, & 
Kraaimaat, 1989; Holt & Andrews, 1989a; Kroeze & van den Hout, 1998; Maddock & 
Carter, 1991; Woods et al., 1986).  
 
Disorganized breathing patterns such as greater tidal volume instability (VTI) 
(Abelson, Weg, Nesse, & Curtis, 2001; Gorman et al., 1988; Wilhelm, Trabert, & Roth, 
2001a, 2001b) or frequent sighing (Abelson, Weg, Nesse, & Curtis, 2001; Wilhelm, 
Trabert, & Roth, 2001a) have distinguished PD patients from controls in numerous 
experiments. Greater VTI was even seen during REM sleep (Gorman et al., 1990; Stein, 
Millar, Larsen, & Kryger, 1995). Gorman et al. (1990) found greater minute ventilation 
(MV) and tidal volume (VT) in PD compared to Social Phobia (SOP) and NAC. Abelson 
et al. (Abelson, Nesse, Weg, & Curtis, 1996; Abelson, Weg, Nesse, & Curtis, 2001) 
replicated this finding of greater MV in PD. Furthermore, they found higher irregularity 
of respiration rate (RR) in the patients.  
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Increased breathing frequency is common in PD compared to NAC (Maddock & 
Carter, 1991), SOP (Holt & Andrews, 1989a), or GAD (Holt & Andrews, 1989a). Rapee 
et al. (Rapee, Brown, Antony, & Barlow, 1992) observed several anxiety disorders during 
two respiratory challenges. At baseline, PD with Agoraphobia, OCD, and GAD had 
higher RR than PD without Agoraphobia or healthy subjects. However, there are 
examples in which RR, VT, and MV were equal in PD and SOP (Asmundson & Stein, 
1994) or NAC (Asmundson & Stein, 1994; Hegel & Ferguson, 1997; Holt & Andrews, 
1989a; Papp et al., 1997).  
 
Resting heart rate (HR) has repeatedly been shown to be elevated in PD compared 
to GAD (Rapee, 1986) or NAC (Bass, Lelliott, & Marks, 1989; Hoehn-Saric, McLeod, 
Funderburk, & Kowalski, 2004; Roth et al., 1992). Bystritsky et al. (Bystritsky, Craske, 
Maidenberg, Vapnik, & Shapiro, 2000) divided their patients into panickers and non-
panickers in response to a CO2 challenge and compared them to healthy subjects.  
Panickers differed in HR and breathing variability from the other groups. On the other 
hand, some studies recorded equal HRs between patients and controls in the laboratory 
(Abelson, Nesse, Weg, & Curtis, 1996; Abelson, Weg, Nesse, & Curtis, 2001; Roth, 
Wilhelm, & Trabert, 1998) or ambulatory (Shear et al., 1992).  
 
Voluntary Hyperventilation 
Symptoms of HV and of acute panic often overlap (Bass, Lelliott, & Marks, 1989; 
Bonn, Readhead, & Timmons, 1984; Cowley & Roy-Byrne, 1987; Gorman et al., 1984; 
Hibbert & Pilsbury, 1988; Maddock & Carter, 1991; Rapee, 1986). Some studies, though, 
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failed to show a link between hypocapnia and naturally occurring panic attacks (Garssen, 
Buikhuisen, & van Dyck, 1996; Hibbert & Pilsbury, 1988, 1989). Nevertheless, voluntary 
HV has widely been used as a respiratory agent to provoke panic in PD, and has 
repeatedly evoked a stronger psychophysiological response than in comparison groups. 
An increase in anxiety and panic symptoms is typical during HV, but usually with greater 
increases in PD than NAC (Gorman et al., 1984; Holt & Andrews, 1989a, 1989b; 
Maddock & Carter, 1991; Nardi, Valenca, Nascimento, & Zin, 2002b; Wilhelm, Gerlach, 
& Roth,, 2001). The same is the case for other anxiety disorders (Nardi, Valenca, 
Nascimento, & Zin, 2002b; Rapee, 1986; Wilhelm, Gerlach, & Roth, 2001) or even 
depression (Nardi, Valenca, Nascimento, & Zin, 2001). In Bass et al.’s (Bass, Lelliott, & 
Marks, 1989) study, only patients who reported that symptoms produced by HV were 
similar to their usual panic, had more somatic symptoms during recovery than controls.  
A number of studies have shown that HV elicits more panic attacks in PD than NAC 
(Maddock & Carter, 1991; Martinez et al., 1998; Nardi, Valenca, Nascimento, & Zin, 
2001, 2002b; Nardi et al., 2006; Papp et al., 1997). However, in a study by Gorman et al. 
(1994), numbers of panic attacks were only different between groups according to the 
patients’ self-report, not according to the judgment of an outside assessor. Another study 
applied a HV challenge to healthy volunteers and various anxiety disorder patients (Holt 
& Andrews, 1989a). The authors found that panic patients had smaller VTs than NAC 
during HV, which they interpreted as a restriction of breathing depth due to fear of the 
consequences of the provocation. 
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A common phenomenon in PD is slower psychophysiological recovery from HV. 
Wilhelm et al. (Wilhelm, Gerlach, & Roth, 2001) investigated PD, SOP, and NAC during 
several periods of brief HV. They found greater anxiety in PD and SOP compared to 
controls at baseline, HV, and recovery. PD patients exhibited more panic attacks during 
recovery but were equal to SOP during HV itself. Moreover, PD showed slower recovery 
of pCO2, HR, and skin conductance level (SCL), and higher scores on most self-reported 
respiratory items than the two other groups. Ball and Shekkar (1997) found more 
dizziness in PD during recovery from 30 seconds of overbreathing compared to NAC. 
Patients also exhibited greater baseline dizziness, but the differences during recovery 
were not accounted for by them. Gorman and colleagues (1988) divided their patients 
into panickers and non-panickers. The first group had lower pCO2 levels during HV 
recovery than non-panickers and controls. The same pattern was seen in another study: 
panicking patients showed slower pCO2 recovery and a greater increase in RR compared 
to baseline (Maddock & Carter, 1991). Friedman et al. (Friedman, Mathis, Hayes, 
Renshaw, & Dager, 2006) also observed slower recovery of pCO2 in PD.  
 
However, some studies have failed to find more panic attacks in PD during HV 
(Bass, Lelliott, & Marks, 1989; Gorman et al., 1988; Griez & Schruers, 1998; 
Zandbergen, Lousberg, Pols, de Loof, & Griez, 1990) or could only show a difference in 
self-report but not physiological measures. In a recent study from our laboratory 
(Wollburg, Roth, Conrad, Meuret, & Kim, in press) we investigated PD patients and 
healthy volunteers during two levels of HV and did not find the differences in the 
physiological measures reported in previous experiments (see above). Rapee (1986) 
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compared PD and GAD patients on their reaction to brief HV and found no differences in 
change values of pCO2 or VT from baseline to recovery. Moreover, similar increases in 
HR during HV were seen in both groups. However, PD patients experienced more 
symptoms during HV and rated them as more intense. In a later experiment (Rapee, 
Brown, Antony, & Barlow, 1992), the PD group showed a greater response than other 
anxiety disorders or NAC. PD patients exhibited more fear, anxiety, and physical and 
other cognitive symptoms of anxiety, and rated them as more intense. A study conducted 
by Asmundson & Stein (1994) with PD and SOP patients found no group differences in 
any of the physiological measures recorded, but both patient groups exhibited more panic 
attacks and a higher global symptom severity score than NAC. Whittal & Goetsch (1995) 
applied a 2 minute HV challenge to PD patients, infrequent panickers, and panic-free 
subjects with either low or high anxiety (based on the State-Trait Inventory). They found 
no group differences in physiological measures but in sensations and cognitions. Panic-
free, low anxiety subjects endorsed less intense sensations and anxious cognitions than 
the other three groups. PD patients and infrequent panickers exhibited more intense 
cognitions during HV than the other two groups.  
 
Voluntary Hypoventilation 
Underbreathing as well as overbreathing can cause panic responses. 
Hypoventilation (HYPO) induced by inhalation of CO2-enriched gas mixtures is one of 
the most widely studied laboratory markers of PD. Subjects inhale CO2-enriched air of 
varying concentrations for a prolonged time, or take single- or double-vital capacity 
breaths of such air. Although less frequently used, hypercapnia (high CO2 level) can also 
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be produced by breath-holding (BH) (Asmundson & Stein, 1994; Rassovsky, Abrams, & 
Kushner, 2006; Roth, Wilhelm, & Trabert, 1998). Typically the breath is held as long as 
possible by the subject, or subjects rebreathe their own exhaled CO2 (Katzman et al., 
2002; Papp, Martinez, Klein, Coplan, & Gorman, 1995). A general criticism of these 
methods is that CO2 concentrations are usually higher than those occurring naturally. Too 
high concentrations may obliterate differences between experimental and control groups 
(Papp, Klein, Martinez et al., 1993; Papp et al., 1997). For instance, Gorman et al. (1988) 
showed that with 5% CO2, PD groups experienced more panic attacks than other anxiety 
disorders or NAC, but the differences between the patient groups disappeared with 7% 
CO2. Nevertheless, inhaling CO2 appears to be a very reliable panicogenic agent. 
Comparison studies of HV and HYPO often yielded the result that the latter is a more 
potent anxiogenic stimulus (Gorman et al., 1984, 1988, 1994; Papp et al., 1997; 
Zandbergen, Lousberg, Pols, de Loof, & Griez, 1990). 
 
In numerous experiments, an exaggerated response to CO2 inhalation has been 
observed in PD compared to healthy controls (Bystritsky & Shapiro, 1992; Gorman et al., 
1984, 1994; Griez, de Loof, Pols, Zandbergen, & Lousberg, 1990; Kent et al., 2001; 
Papp, Klein, Martinez et al., 1993; Papp et al., 1997; Schmidt, Forsyth, Santiago, & 
Trakowski, 2002; Rassovsky, Abrams, & Kushner, 2006; van den Hout, Marcel A., van 
der Molen, Griez, Lousberg, & Nansen, 1987; Woods, Charney, Goodman, & Heninger, 
1988), other anxiety disorders (Griez, de Loof, Pols, Zandbergen, & Lousberg, 1990; 
Nardi et al., 2003; Papp, Klein, Martinez et al., 1993; Perna, Gabriele, Caldirola, & 
Bellodi, 1995), and depression (Kent et al., 2001). Schmidt et al. (Schmidt, Forsyth, 
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Santiago, & Trakowski, 2002) found a greater response to CO2 in both self-report and 
physiology. They subtyped their PD patients and NAC based on subjective distress and 
autonomic arousal during 35% CO2 inhalation and found that the majority could be 
classified as either prototypic panic (presence of subjective distress and arousal) or 
cognitive panic (presence of subjective distress, but only minimal arousal).  
 
Gorman and colleagues (2001) observed lower resting pCO2 levels in PD patients 
who subsequently panicked to 5% CO2 inhalation than in non-panicking PD. Compared 
to depression, premenstrual dysphoric disorder, and non-anxious controls, panic attacks 
were triggered more often in patients with PD and premenstrual dysphoric disorder. The 
stronger reaction to CO2 was due to an occurrence of a panic attack, but not associated 
with the diagnostic group which led to the conclusion that the panic reaction involves a 
generalized fear response and can therefore occur in subjects without a diagnosis of PD. 
Similar results were obtained by Kent et al. (2001). Verburg and colleagues (Verburg, 
Griez, Meijer, & Pols, 1995) observed that PD patients had a greater increase in anxiety 
to 35% CO2 than did GAD patients, but that total panic symptom scores rose 
equivalently. The authors concluded that an increase in anxiety in reaction to CO2 
inhalation is specific to PD, but not an increase in panic symptoms. Some researchers 
have speculated that certain subgroups of non-PD anxiety disorders are prone to the same 
false suffocation alarms as PD (Caldirola, Perna, Arancio, Bertani, & Bellodi, 1997; 
Perna, Gabriele, Caldirola, & Bellodi, 1995). One repeatedly observed sign of an 
exaggerated response to CO2 in PD is premature termination of CO2 inhalation (Gorman 
et al., 1994; Papp et al., 1997; Rassovsky, Abrams, & Kushner, 2006) or premature 
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termination of BH (Asmundson & Stein, 1994).  However, some HYPO studies have 
only found effects in the self-report domain when PD was compared to other anxiety 
disorders (Asmundson & Stein, 1994; Rapee, Brown, Antony, & Barlow, 1992; Verburg, 
Griez, Meijer, & Pols, 1995) or NAC (Lynch, Bakal, Whitelaw, Fung, & Rose, 1992; 
Rapee, Brown, Antony, & Barlow, 1992; Woods, Charney, Goodman, & Heninger, 
1988). Other studies did not find any CO2 hypersensitivity in PD compared to NAC 
(Gorman et al., 1990; Katzman et al., 2002; Roth et al., 1992; Roth, Wilhelm, & Trabert, 
1998) or other anxiety disorders (Antony, Brown, & Barlow, 1997; Caldirola, Perna, 
Arancio, Bertani, & Bellodi, 1997; Gorman et al., 1990; Roth, Wilhelm, & Trabert, 
1998).  
 
 
In summary, respiratory abnormalities at baseline and in response to over- or 
underbreathing, have often appeared specific for PD (Griez, de Loof, Pols, Zandbergen, 
& Lousberg, 1990; Nardi, Valenca, Nascimento, & Zin, 2002b; Nardi et al., 2003; Papp, 
Klein, Martinez et al., 1993; Perna, Gabriele, Caldirola, & Bellodi, 1995; Rapee, 1986; 
Wilhelm, Gerlach, & Roth, 2001). On the other hand, some studies indicated that a 
greater reaction to voluntary HV and CO2 inhalation is not necessarily specific to PD. In 
several studies, equal responses were observed in PD and non-PD anxiety disorders 
(Antony, Brown, & Barlow, 1997; Asmundson & Stein, 1994; Caldirola, Perna, Arancio, 
Bertani, & Bellodi, 1997; de Ruiter, Ruken, Garssen, & Kraaimaat, 1989; Gorman et al., 
1990; Rapee, Brown, Antony, & Barlow, 1992) or NAC (Antony, Brown, & Barlow, 
1997 Asmundson & Stein, 1994; Bass, Lelliott, & Marks, 1989; Carter, Suchday, & 
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Gore, 2001; Caldirola, Perna, Arancio, Bertani, & Bellodi, 1997; Ehlers et al., 1986; 
Griez & Schruers, 1998; Gorman et al., 1988, Gorman et al., 1990; Holt & Andrews, 
1989b). 
 
How can these inconsistencies be explained? The possibility of subtypes of panic 
that are associated with different reactions to biological challenges has been raised by 
several researchers (Biber & Alkin, 1999; Hegel & Ferguson, 1997; Ley, 1992). A 
common distinction among panic patients has been posited, namely, differentiating 
between “respiratory” and “non-respiratory” subtypes based on symptoms during usual 
attacks. Research has shown that the first subtype has a higher sensitivity to biological 
challenges than the latter (Abrams, Rassovsky, & Kushner, 2006; Biber & Alkin, 1999; 
Nardi et al., 2006; Valença, Nardi, Nascimento, Zin, & Versiani, 2002). Typically, the 
definition introduced by Briggs et al. (Briggs, Stretch, & Brandon, 1993) has been used. 
On the basis of cluster analysis and principal component analysis, Briggs et al. (Briggs, 
Stretch, & Brandon, 1993) found a subgroup with prominent respiratory symptoms 
defined as the presence of at least 4 of the following symptoms: shortness of breath, 
choking/smothering sensations, chest pain/discomfort, tingling/numbness, or fear of 
dying. The residual group endorsed fewer than 4 of those. It is obvious that a cognitive 
symptom (fear of dying) was part of the respiratory subtype but dizziness, a clear HV 
symptom, was not included. In a recent study (Meuret et al., 2006), a three-factor solution 
for symptom dimensions from intensity ratings of the DSM-IV panic attack symptoms 
was found: cardio-respiratory, autonomic/somatic, and cognitive subtypes of panic 
attacks. This study confirmed the very early results by Cox et al. (1994). Another 
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classification by Schmidt et al. (Schmidt, Forsyth, Santiago, & Trakowski, 2002) was 
based on subjective distress and autonomic arousal in response to CO2 inhalation. They 
distinguished between prototypic (high subjective distress, high arousal), cognitive (high 
subjective distress, low arousal), and nonfearful (low subjective distress, high arousal) 
attacks. The first two were dominantly found in PD in response to the challenge. Finally, 
a distinction made by early studies was between panickers and non-panickers in response 
to HV or CO2 inhalation (Gorman et al., 1988; Maddock & Carter, 1991).  
 
 
Physiological Theories of Panic Disorder 
 
Currently, there are two prominent respiratory theories of PD, both of which 
postulate a role for HV: Ley’s Hyperventilation Theory and Klein’s Suffocation False 
Alarm Theory. One views HV as the cause and one as the consequence of panic. Ley’s 
model (1985) proposes that panic attacks are caused by HV and the misinterpretation of 
its symptoms. Later he added a vicious circle mechanism, a lowered threshold for panic 
due to chronic HV, and an emphasis on the automatic fear-eliciting nature of involuntary 
dyspnea (Ley, 1987, 1989). If the state of hypocapnia (low pCO2) persists and dyspnea is 
perceived as incontrollable and life-threatening, a panic attack will occur. At some point 
in the learning history of the patient, HV and accompanying symptoms led to anxiety 
which intensified HV and accompanying symptoms, creating a vicious circle ending in 
panic. A further elaboration of the theory focused on the distinction between different 
kinds of panic attacks - respiratory, cognitive, and anticipatory – characterized by 
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different psychological and physiological symptoms (Ley, 1992). Evidence for the 
hyperventilation theory comes from studies that observed lower basal pCO2 in PD (Hegel 
& Ferguson, 1997; Papp et al., 1997; Rapee, 1986; Roth, Wilhelm, & Trabert, 1998; 
Salkovskis, Jones, & Clark, 1986), a co-occurence of hypocapnia and panic attacks 
(Gorman et al., 1988; Griez & van den Hout, 1987; Salkovskis, Warwick, Clark, & 
Wessels, 1986), a stronger psychological response to voluntary HV (Antony, Brown, & 
Barlow, 1997; Gorman et al., 1994; Holt & Andrews, 1989a), or a slower recovery from 
HV (Gorman et al., 1988; Maddock & Carter, 1991; Wilhelm, Gerlach, & Roth,, 2001). 
However, as noted above, hypocapnia is not always present in PD at baseline (Holt & 
Andrews, 1989a, Woods et al., 1986) or during panic attacks (Garssen, Buikhuisen, & 
van Dyck, 1996; Hibbert & Pilsbury, 1988). Ley suggested that possibly only initial or 
severe panic attacks are accompanied by hypocapnia. Other contrary findings include 
observations of hypocapnia in anxiety disorders other than PD (van den Hout et al., 1992) 
and the fact that hypercapnea appears to be a better panicogenic agent than HV (Gorman 
et al., 1984, 1994; Papp et al., 1997; Rapee, Brown, Antony, & Barlow, 1992) 
 
The basic tenet of the Suffocation False Alarm Theory is that hypercapnia, or less 
often hypoxia, causes panic (Klein, 1994). According to Klein, PD patients are 
particularly sensitive to hypercapnia but may react secondarily to suffocation feelings 
with HV or frequent sighing. He assumes a faulty, overly sensitive physiological 
mechanism, a suffocation alarm monitor that is triggered when the oxygen supply is not 
actually being compromised, falsely signalling hypoxia (Klein, 1993). As a result, 
patients experience a feeling of suffocation or dyspnea that causes sudden respiratory 
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distress and panic. Furthermore, Klein states that the set point for the alarm may be lower 
in PD or just spontaneously fires. Therefore, patients may hyperventilate to create a 
buffer zone and keep the CO2 level below the threshold that would trigger a false alarm 
by incidental fluctuations. Opposite from Ley, chronic HV in PD is seen as an adaptive, 
compensative mechanism rather than a cause of panic. Klein describes three types of 
panic associated with different psychological and physiological symptoms (Klein & 
Klein, 1989): spontaneous panic, stimulus-bound panic, and situationally predisposed 
panic.  
 
A number of findings support this model, for instance, studies that showed an 
exaggerated response of PD patients to CO2 inhalation (Gorman et al., 1994, 2001; Nardi 
et al., 2003; Rapee, Brown, Antony, & Barlow, 1992), premature termination of CO2 
inhalation (Papp et al., 1997) or of BH (Asmundson & Stein, 1994) as an attempt to avoid 
activating the suffocation monitor, greater chemoreceptor sensitivity (Lousberg, Griez, & 
van den Hout, 1988), and greater responses to provocations such as breath holding 
(Asmundson & Stein, 1994; Rassovsky, Abrams, & Kushner, 2006) and lactate infusions 
(Gorman et al., 1988; Sloan et al., 1999). Lactate is a signal to the suffocation alarm 
monitor that causes central chemoreceptors to misinterpret fluctuations in pH as life-
threatening hypoxia. Slower recovery from HV can be interpreted by this model as a 
reluctance of patients to let their CO2 rise. However, not all studies have found PD-
specific hypersensitivities to hypercapnia or a lower threshold (Antony, Brown, & 
Barlow, 1997; Caldirola, Perna, Arancio, Bertani, & Bellodi, 1997; Gorman et al., 1990; 
Katzman et al., 2002; Roth, Wilhelm, & Trabert, 1998; Schmidt, Telch, & Jaimez, 1996). 
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Treatment of Breathing Abnormalities 
 
The panicogenic effects of breathing challenges can be altered by successful 
treatment of PD (Gorman, Martinez, Coplan, Kent, & Kleber, 2004; Martinez et al., 
2001; Meuret, Wilhelm, Ritz & Roth, in press; Salkovskis, Jones, & Clark, 1986; 
Schmidt, Lerew, & Jackson, 1997; Sullivan et al., 2004; Valença, Nardi, Nascimento, 
Zin, & Versiani, 2002a). Since respiratory abnormalities have been found for decades to 
be present in PD, treatment programs have been developed that are aimed at modifying 
pathogenic breathing. They are usually based on a HV model and hence aimed at 
reversing hypocapnia and reducing dysfunctional respiration by teaching slow, abdominal 
breathing with the help of audiotapes, simple breath counting, or capnographic feedback 
(Meuret, Wilhelm, & Roth, 2001; Meuret, Wilhelm, Ritz & Roth, 2003). Additionally, 
patients learn to reinterpret their physical symptoms as part of a normal bodily reaction, 
the fight-flight response. Several studies have applied variations of BT alone to PD 
patients (Clark, Salkovskis, & Chalkley, 1985; Hibbert & Chan, 1989; Salkovskis, Jones, 
& Clark, 1986) or as one component of a treatment package (Bonn, Readhead, & 
Timmons, 1984; Craske, Rowe, Lewin, & Noriega-Dimitri, 1997; Schmidt et al., 2000), 
and have shown therapeutic benefits. However, not all studies found BT to be 
efficacious; as part of treatment packages it has produced mixed results. For instance, 
Craske et al. (Craske, Rowe, Lewin, & Noriega-Dimitri, 1997) and Schmidt et al. (2000) 
did not find an additive effect of BT following CBT. Some researchers assume that only 
PD patients who recognize a similarity between the symptoms produced by HV and those 
usually experienced during their panic attacks benefit from BT. Bonn et al. (Bonn, 
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Readhead, & Timmons, 1984), for example, only offered BT to those patients who 
responded to a HV challenge. Even cognitive approaches (Clark, 1986) ascribe a role to 
HV, albeit a secondary one. CBT focuses on the maladaptive interpretation of symptoms 
that causes PD patients to hyperventilate and become anxious. Skills for combating HV 
may be used as a safety-aid and therefore counteract the rationale of CBT (Craske, Rowe, 
Lewin, & Noriega-Dimitri, 1997; Schmidt et al., 2000). Proponents of BT on the other 
hand argue that this approach could lead to a false assumption that HV is normal and 
does not need treatment.  
 
Studies giving BT to patients with anxiety disorders seldom record physiological 
measures (see Wollburg, Kim, Conrad, & Roth, 2007). This is a flaw since physiological 
processes are the main target of the treatment. Few studies used respiratory measures as 
part of the outcome evaluation. Salkovskis et al. (Salkovskis, Jones, & Clark, 1986) 
found a lower resting pCO2 in patients with panic attacks than in controls, which 
normalized with treatment by paced breathing. A study carried out by Bonn and 
colleagues (Bonn, Readhead, & Timmons, 1984) showed that diaphragmatic breathing in 
combination with exposure in agoraphobics was superior at the 6-months follow up 
assessment in terms of RR and some clinical measures, for instance, the elimination of 
panic attacks. Our laboratory has developed a respiratory biofeedback-assisted therapy 
for PD in which people are trained to raise their end-tidal pCO2 by slow, diaphragmatic 
breathing (Meuret, Wilhelm, & Roth, 2001; Meuret, Wilhelm, Ritz, & Roth, in press). 
Results also showed a lower basal pCO2 before treatment and an increase to normal 
levels after BT along with improvement on clinical measures. In the current study we 
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expanded this treatment. PD patients were randomly assigned to two different therapy 
groups that teach either anti-hyperventilatory breathing or lowering of end-tidal pCO2. 
The first therapy is in line with Ley’s theory, the latter with Klein’s. 
 
 
Respiratory Abnormalities in other Anxiety Patients 
 
Respiratory abnormalities have been shown to be present in anxiety disorders 
other than PD. Wilhelm et al. (Wilhelm, Trabert, & Roth, 2001a, 2001b) observed lower 
basal pCO2 and increased VTI and sighing in both PD and GAD. Driving phobia patients 
without PD showed significant hypocapnia and increased respiratory variability while 
driving (Alpers, Wilhelm, & Roth, 2005). Furthermore, hypersensitivity to respiratory 
challenges has also been found in phenomenologically related conditions, including 
limited symptom episodes (Schmidt, Lerew, & Jackson, 1997). CO2 inhalation provokes 
a panic response in patients without PD, even if milder than in PD (Gorman et al., 1990; 
Gorman et al., 2001; Papp, Klein, Martinez et al., 1993; Perna et al., 1994; Perna, 
Gabriele, Caldirola, & Bellodi, 1995; Rapee, Brown, Antony, & Barlow, 1992).  
Caldirola et al. (Caldirola, Perna, Arancio, Bertani, & Bellodi, 1997) found the same 
increase in anxiety in PD and SOP in response to CO2 inhalation; Nardi et al. (Nardi et 
al., 2003) showed that PD did not differ in the increase in anxiety to SOP and GAD in 
reaction to BH. These findings indicate that similar false suffocation alarm monitors to 
the ones postulated for PD may also be present in other anxiety disorders or subgroups of 
them. Perna et al. (Perna et al., 1994; Perna, Gabriele, Caldirola, & Bellodi, 1995) have 
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shown that clinical severity of PD is unrelated to the vulnerability to CO2 inhalation. 
They conclude that regardless of the diagnostic group, the experience of panic attacks 
during CO2 inhalation rather than meeting the full criteria for PD accounted for the 
exaggerated response. Furthermore, respiratory control has been successfully applied in 
patients with panic attacks (e.g., Salkovskis, Jones, & Clark, 1986; van den Hout, Marcel 
A., van der Molen, Griez, Lousberg, & Nansen, 1987). In addition, many patients suffer 
from anxiety attacks that do not meet full DSM criteria for panic attacks. In a study by de 
Beurs et al. (1994) only 60% of the recorded attacks fulfilled DSM criteria of at least four 
symptoms. About 20% of the panic attacks involved only one severe symptom or only 
mild symptoms, and about the same percentage of episodes lasted longer than an hour. 
The authors conclude that major attacks are predominantly long-lasting and that just one 
symptom, if intense enough, can lead to the subjective judgment of a panic attack.  
Margraf et al. (Margraf, Taylor, Ehlers, Roth, & Agras, 1987) found that the average 
panic attack in their sample lasted about a half hour and concluded that “any cutoff above 
two symptoms is arbitrary”. These results give rise to the question of how people with 
anxiety attacks with only two accompanying DSM-IV panic attack symptoms would 
react to respiratory challenges.  
 
The primary goal of the study reported here was to investigate whether treatment 
with one of two kinds of breathing retraining (hypocapnic vs. hypercapnic breathing) 
would attenuate the psychophysiological reactions of PD patients to hypoventilation and 
hyperventilation. In accordance with the majority of recent psychophysiological findings, 
we hypothesized that PD would have a stronger psychophysiological reaction than NAC 
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to both respiratory challenges. After treatment, both treatment conditions would show 
less psychological and physiological distress to the challenges since the therapy targeted 
normalization of respiration. Patients in the hypercapnic condition would have higher, 
and patients in the hypocapnic lower resting pCO2 levels. Hence, we expected that 
patients in the first condition would reach higher pCO2 levels at the end of HYPO and 
recovery faster from HV at post-treatment than patients who received the hypocapnic 
treatment. The two groups would not differ in their ability to hyperventilate since HV is a 
procedure that is easier to carry out than HYPO. In addition to PD patients, the study 
reported below investigated a second patient population suffering from subclinical panic 
attacks, which we termed Episodic Anxiety (EA) patients. Since they show a clinical 
overlap with PD, there is reason to assume similar but possibly milder reactions to 
respiratory challenges, and a benefit from breathing training. We hypothesized that the 
EA patients would show a similar but milder response than panic patients to the 
respiratory challenges, which would be further attenuated by treatment. 
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METHOD 
 
Inclusion Criteria 
 
This study compared Panic Disorder and Episodic Anxiety patients with non-
anxious controls. Participants were recruited from the general population of the Peninsula 
and San Francisco South Bay region. PD patients must have met current DSM-IV 
diagnosis of Panic Disorder with or without Agoraphobia and must have been willing to 
undergo a 5-session course of breathing training and accept the possibility of an 8-week 
treatment delay if assigned to the waitlist group. People with a history of schizophrenia, 
bipolar disorder, dementia, alcohol or drug abuse in the preceding year and/or current use 
of recreational drugs or more than 15 alcoholic drinks per week, a current score on the 
Beck Depression Inventory exceeding 30, or current suicidality were excluded. 
Moreover, subjects who had to be maintained on drugs with pronounced sympathetic, 
parasympathetic (e.g. beta-blockers, tricyclic antidepressants), or respiratory effects (e.g. 
bronchodilators), or those who used short-acting benzodiazepines (e.g. alprazolam) in 
excess of 2.0 mg/day in the preceding month, or longer-acting benzodiazepines or 
shorter-acting anxiolytics in the two weeks prior to evaluation were not included. Patients 
taking selective serotonin reuptake inhibitors (SSRIs), other antidepressants, or short-
acting benzodiazepines less than 2.0 mg/day must have been on a stable dose for the 
duration of the study or have stopped taking the medication while participating. Medical 
reasons for exclusion were pregnancy, history of myocardial infarction, congestive heart 
failure, clinically significant asthma, emphysema, or a blood pressure above 160/100.  
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The EA patients were a more broadly defined chronically anxious population with 
anxiety attacks. The main complaint of these patients was subclinical panic attacks 
(episodic anxiety attacks) either as part of a DSM-IV disorder or as the sole complaint (in 
which case patients were diagnosed with Anxiety NOS). DSM-IV defines limited 
symptom attacks as having fewer than 4 of the panic attack symptoms. However, we 
specified that at least 2 symptoms had to be present in order to qualify as an episodic 
anxiety attack. Furthermore, these attacks could have been expected or unexpected, did 
not have to develop abruptly, and could have lasted for minutes up to several hours. The 
same exclusion criteria applied to this group as to the PD patients with one exception: if 
unexpected full-blown panic attacks were experienced, they had to be related to a 
disorder other than PD. Inclusion criteria for controls were the same as those of PD and 
EA patients, except that controls could have not met current criteria for any psychiatric 
disorder.  
 
 
Participant Characteristics 
 
Twenty NAC, 45 PD, and 39 EA patients participated in the current study. Six  
(13 %) PD and four (10 %) EA patients dropped out between initial assessment and the 
one-month follow up. Furthermore, 2 control subjects (10%), 13 (28.9 %) PD and 4  
(10.3 %) EA patients were unable to raise their CO2 above baseline during 
hypoventilation, whereas all participants were able to lower their CO2. One PD patient 
had to stop the procedure because it was too anxiety-provoking, and one EA patient was 
unable to undergo the tests due to high blood pressure. All subjects who reacted contrary 
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to the instruction of the initial hypoventilation test, i.e., decreased instead of increased 
their pCO2, were excluded from the analyses of the psychophysiological data. A total of 
18 controls, 31 PD, and 32 EA patients remained. People who complied with the 
instructions and those who did not, were comparable on demographic and clinical 
variables.  
 
Table 1 
Demographic Characteristics by Group  
 PD  
(N = 45) 
EA 
(N = 39) 
NAC 
(N = 20) 
χ2, z, or 
F - ratio 
p 
Women (%) 66.7 68.6 55.0 χ2 = 1.13 p = 0.57 
Age (years) 41.8 (12.7) 46.7 (11.2) 45.7 (12.5) F = 259.92 p = 0.18 
BMI (kg/m2) 25.5 (4.66) 23.4 (3.93) 25.4 (4.03) F = 2.71 p = 0.07 
Fitness level (0-3)a 31.42 52.9 54.7 χ2 = 19.05 p = 0.00 
Ethnicity (%) 
   Hispanic 
   Not Hispanic 
   Declined to report 
   Missing 
 
15.6 
51.1 
17.8 
15.6 
 
5.13 
69.2 
7.69 
7.69 
 
5.00 
90.0 
5.00 
0.00 
 
 
      χ2 = 5.76 
 
 
p = 0.22 
Race (%) 
   Caucasian 
   African-American 
   Asian 
   Native Hawaiian or  
     other Pacific Islander 
   More than one race 
   Declined to report 
   Missing 
 
40.0 
2.22 
13.3 
4.44 
 
4.44 
15.6 
20.0 
 
51.3 
25.6 
13.9 
0.00 
 
5.13 
0.00 
12.8 
 
60.0 
0.00 
30.0 
0.00 
 
0.00 
10.0 
0.00 
 
 
 
 
      χ2 = 9.20 
 
 
 
 
p = 0.51 
Note. Values are expressed as percentages, means (standard deviations), or mean ranks; PD = 
Panic Disorder; EA = Episodic Anxiety; NAC = Non-anxious Controls; BMI = Body Mass 
Index; χ2 from contingency tables; a0 = not very active, 1 = weekend exerciser, 2 = at least 1-
2 times a week active, 3 = 3 or more times a week active, F values from one-way ANOVAs.  
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Groups were matched on age, sex, body mass index, race, and ethnicity (see Table 
1). Non-anxious controls had a mean age of 45.7 years and were 55% women. The PD 
and EA group’s mean ages were 41.8 years with 67% women and 46.7 years with 69% 
women, respectively. However, the PD patients were less active than EA patients and 
NAC, who did not differ from each other. The majority of the panic group was diagnosed 
with PD with Agoraphobia (62.2%), in all of whom of mild to moderate severity. EA 
patients mostly suffered from Anxiety NOS (38.5%), also with mild to moderate severity. 
About one third of the PD (37.8%) and EA (38.5%) patients had an additional DSM-IV 
diagnosis. A complete list of all primary diagnoses and comorbidities can be found in the 
appendix.  
 
Fifty-three percent of PD, 69% of EA patients, and 50% of the NAC were taking 
medication on a regular basis and had often more than one kind. Twenty-two percent of 
PD patients were taking anxiolytics (8, benzodiazepines; 2, buspirone), 2% beta-blockers 
(1, propanolol), 2% non-sedating antihistamines (1, fexofenadine), and 33% took 
antidepressants (10, SSRIs; 1, tricyclic antidepressants; 2, venlafaxine; 1, bupropion; 1, 
mirtrazapine). Thirty-three percent of the EA patients were taking anxiolytics (13, 
benzodiazepines), 8% antihistamines (1, fexofenadine; 1, loratadine; 1, cetirizine), and 
23% antidepressants (5, SSRIs; 2, bupropion; 2, venlafaxine; 1, nortriptyline). Five 
percent of NAC were taking anxiolytics (1, benzodiazepines) and 5% antihistamines (1, 
claritin). Thyroid medication was taken by 9% of PD patients and 10% of NAC. Twenty 
percent of PD patients, 51% of EA patients, and 40% of NAC were taking other 
medication with no effects on our physiological recordings and hence not listed in detail.  
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Procedure 
 
Potential subjects were screened over the phone with questions about their mental 
and physical health to check for initial eligibility. At the first visit, subjects gave written 
informed consent and afterwards were administered diagnostic interviews and underwent 
the psychophysiological assessment (see below). Patients were randomly assigned to 
either one of two immediate treatment groups or a waiting list (WL). Immediate 
treatment groups began therapy one week after the initial assessment; the WL had a 
waiting period of 8 weeks. The same psychophysiological assessment was conducted one 
month after completion of the therapy and eight weeks after the initial assessment for 
NAC and WL patients to match the time.  
 
 
Treatment 
 
Therapy consisted of five weekly sessions of biofeedback-assisted breathing 
training and practice of breathing exercises at home on a daily basis. Patients were 
randomly assigned to one of two therapy groups: hypercapnic (Raise-CO2)1 versus 
hypocapnic (Lower-CO2)2 breathing. The first treatment was based on the theory that HV 
causes or contributes to panic attacks; the latter on the opposite assumption, namely that 
high CO2 causes or contributes to panic attacks. Both therapeutic approaches were 
comparable on important variables such as duration of therapy, patient-therapist 
interaction, direction of attention to bodily sensations, goal of regular breathing, use of a 
                                                 
1 In the following, we will refer to this group as “Raise”. 
2 In the following, we will refer to this group as “Lower”. 
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capnometer, and plausibility of the treatments - only the target pCO2 level was different. 
The breathing training was applied by graduate students from a local graduate school of 
psychology, a graduate student in a German psychology program, and a licensed 
psychologist.  
 
Treatment included education on the physiology of breathing and anxiety, the 
rationale of the particular treatment (hyperventilation theory or suffocation false alarm 
theory), and review of the homework breathing exercises. Patients conducted the 
exercises at home twice a day using a portable capnometer (Tidal Wave Sp, Model 715, 
Novametrix Medical System Inc.) with an internal memory that samples exhaled gas 
drawn from a nasal cannula and records end-tidal pCO2, RR, HR, and oxygen saturation. 
The breathing exercises consisted of three parts: a 2 minute baseline, 10 minutes of paced 
breathing by an audiotape, and another 5 minutes of breathing in a different way  
(depending on the therapy condition) without a pacing aid. The tone pattern of the 
audiotape was set to correspond to 9 breaths per minute with rising tones indicating 
inhalation and falling tones, exhalation. During the last two parts, patients were supposed 
to breathe more deeply or shallowly to reach the required target pCO2 level of 30 mm Hg 
(Lower condition) or 40 mm Hg (Raise condition), respectively, while getting visual 
feedback from the capnometer. Levels much lower than 30 or higher than 40 were 
discouraged since they are hard to maintain and can lead to unpleasant physical 
sensations of dizziness or shortness of breath. After each part of the exercise, patients 
filled out a breathing log that asked about their psychological symptoms and physical 
sensations on 21 items. Once breathing exercises were carried out properly, patients were 
encouraged to apply the breathing whenever they felt anxious or panicky.  
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Psychological Assessment 
 
Diagnostic Interviews 
A multi-modal assessment battery was administered to all participants that 
consisted of clinician-administered as well as self-rated measures. On the day of the 
assessments, participants underwent the Structured Clinical Interview for DSM-IV-TR 
AXIS I Disorders - Research Version (SCID-I; First, Gibbon, Spitzer, & Williams, 2002). 
PD patients were additionally given the Panic Disorder Severity Scale (PDSS; Shear et 
al., 1997), a clinician-rated instrument that assesses severity of PD. EA patients were 
interviewed and rated on the Episodic Anxiety Scale (EAS, unpublished, see appendix). 
The EAS was modified by Walton T. Roth from the PDSS.  It consists of 9 questions 
asking about full-blown and subclinical panic attacks, their duration, predictability and 
distress, as well as about anticipatory anxiety, agoraphobic avoidance, and impairment in 
work and social life.  
 
Questionnaires 
Subjects completed a battery of self-report questionnaires during both 
assessments. A brief summary of each inventory follows.  
 
 Customized Mood Questionnaire (CMQ): The CMQ consists of 17 items that are 
rated each on an 11-point scale from 0 (not at all) to 10 (extremely). Items include 
physical sensations and psychological symptoms (for list see appendix).  
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Anxiety Sensitivity Index (ASI): The ASI was developed by Peterson & Reiss 
(1993) and includes 16 questions related to fears, worries, and concerns about anxiety 
and related somatic sensations that are rated on a five-point Likert scale ranging from      
0 (very little) to 4 (very much). 
 
Mobility Inventory for Agoraphobia (MI): The MI (Chambless, Caputo, Jasin, 
Gracely, & Williams, 1985) is a 27-item inventory for the measurement of agoraphobic 
avoidance behavior and frequency of panic attacks. Avoidance is assessed with 26 
questions and rated for both when the subject is alone and accompanied. These two 
factors are analyzed separately. 
 
Beck Depression Inventory (BDI): The BDI (Beck, Ward, Mendelson, Mock, & 
Erbaugh, 1961) is the most widely used self-report instrument to measure depression. It 
consists of 21 items rated from 0 to 3 and one question with a yes-no answer.  
 
 
Physiological Assessment 
 
After the diagnostic interviews, subjects were led to the laboratory where the 
testing took place in a sound-attenuated chamber while they were seated in a comfortable 
recliner chair. Electrodes were attached and a calibration procedure performed. After that, 
participants went through a procedure consisting of two normal breathing periods, a 
relaxation test, a voluntary hyperventilation test (VHT), and a voluntary hypoventilation 
test (VHO). This paper only focuses on the latter two; results of the others will be 
reported elsewhere. 
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Respiratory Challenges  
The VHT consisted of three segments: a 1 minute baseline, 3 minutes of 
hyperventilation, and an 8 minute recovery period. Participants were instructed to lower 
and maintain their end-tidal pCO2 as close as possible to 20 mm Hg. During the fast 
breathing, they were paced by an audiotape at 18 breaths per minute and received 
feedback from the investigator about their current pCO2, and if necessary, told to breathe 
more shallowly or deeply in order to reach the target; about every 30 seconds if the pCO2 
was stable at the target, otherwise more frequently. The tone on the audiotape varied in 
pitch with an increase indicating inhalation and decrease, exhalation. To minimize 
interpersonal influences, the participants could not see the investigator during the test 
itself.  
 
The VHO consisted of the same segments as the VHT but instead of lowering the 
pCO2, participants were instructed to raise it above baseline while being paced at 6 
breaths per minute. Every breath began with two seconds of inhalation, followed by 
seven seconds of paused breathing, and in the last second, quick and strong exhalation. 
Subjects were also given feedback about their current CO2 level during this test. 
 
Before and after both tests, participants filled out the CMQ. They rated their 
symptoms before the start of the respiratory challenges (baseline) and then 
retrospectively for how they had felt during the paced breathing and during the end of 
recovery. Moreover, they were asked about the occurrence of a panic attack at any point 
of the test, as well as difficulty and discomfort of the tests compared with the other.  
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Physiological Data reduction 
Physiological recordings were analyzed with customized software written by 
Ansgar Cornad in MATLAB® (MathWorks, Natick, MA, USA). Mean levels of every 
measure were calculated for 1 min periods. Measurements more than two standard 
deviations below or above the average for all subjects in that condition and group were 
excluded from statistical analysis as outliers. The following channels were recorded: 
 
1. End-tidal pCO2 was measured continuously by a capnograph  (Nellcor, 
Pleasanton, CA, USA) at a 125 Hz sampling rate, from air drawn from the nostrils 
through a 1.2 mm diameter plastic tube (Adult Nasal CO2 sample line, Salter Labs, 
Arvin, CA, USA). End-tidal pCO2 was determined as the level at which pCO2 stopped 
rising at the end of expiration (final maximum). Expirations in which the pCO2 
waveform did not reach a plateau were deleted and replaced by linearly interpolated 
values. A distinct plateau was defined as having values of less than 3 mm Hg below 
the final maximum for the last 0.25 sec of expiration.  
 
2. Two channels of respiration were sampled at 125 Hz from non-restrictive elastic 
pneumatic belts (James Long Company, Caroga Lake, NY, USA) placed around the 
rib cage of the thorax and the abdomen. Belt expansion was converted to volume 
based on thoracic belt expansions during the calibration procedure while inflating and 
deflating a fixed volume bag. Respiration rate (RR, breaths per minute) and tidal 
volume (VT, volume of air inhaled with each breath) were calculated. Furthermore, 
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the root mean square of successive VT and RR were calculated as tidal volume 
instability (VTI) and respiratory rate instability (RRI). 
 
3. Heart rate (HR) was measured from an electrocardiogram sampled at 20 Hz. 
Electrodes were placed below the left and right collarbone. Artifacts were excluded 
by visual inspection of the recorded data. Respiratory sinus arrhythmia (RSATF) was 
computed based on transfer functions from cross-spectral analysis between HR and 
RR. RSATF values were excluded if spectral coherence between VT- and RR-interval 
was lower than 0.5 since that would indicate sources of variance other than 
respiration (Rottenberg, Wilhelm, Gross, & Gotlib, 2002). 
 
4. Skin conductance level (SCL, EDA Isotonic Gel Electrodes, BioPac Systems) was 
sampled at 125 Hz after a 15 minute stabilization period and analyzed with our usual 
methods (Roth, Wilhelm, & Trabert, 1998). Non-specific conductance fluctuations 
(NSFs) were defined as changes in SCL from consecutive zero-slopes exceeding 0.2 
µSiemens (Roth, Wilhelm, & Trabert, 1998).  
 
 
Statistical Analysis 
 
Patients and controls were compared on a number of self-report and physiological 
measures using the Statistical Package for Social Sciences (SPSS for Windows, version 
15.0, SPSS Inc.).  
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Demographic and Clinical Measures 
Differences in categorical variables such as gender or ethnicity were tested with 
the Kruskal-Wallis or chi square test, depending on whether categories were ordered. 
Continuous variables such as age, PDSS, EAS, or ASI were investigated with one-way 
analyses of variance (ANOVA). Initial and follow-up scores on the questionnaires were 
analyzed using repeated measures ANOVA with the factors Group (PD, EA, NAC) and 
Time (initial assessment, follow-up). Statistical significance was set to p ≤ .05, two-
tailed.  
 
Pre-treatment 
Occurrence of panic attacks was analyzed with chi-square tests. For analysis of 
the repeated psychological and physiological data collected during the respiratory 
challenges, the recommendations of Bagiella, Sloan, and Heitjan (2000) for analyzing 
psychophysiological data were followed. We used mixed-effects models fitted by 
maximum likelihood and assuming first-order autoregressive variance covariance 
structures with homogenous variances (AR1) to examine potential main effects or 
interactions. Factors were entered as fixed effects. Significant effects were followed up 
with Fishers LSD (least significant difference) statistic.  
 
Psychological data were collected at three time points. Hence, each item on the 
CMQ was analyzed with Group (PD, EA, NAC) x Time (baseline, paced breathing, 
recovery) x Condition (HV, HYPO) mixed-effect models. Physiological data were first 
investigated separately for all three segments of the respiratory tests. At baseline, data 
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were analyzed with Group (PD, EA, NAC) x Condition (HV, HYPO) mixed-effect 
models. During paced breathing, Time (min 1, 2, 3) x Group (PD, EA, NAC) x 
Condition (HV, HYPO) models were used. During recovery, analyses were run similar to 
the paced breathing segment except for using 8 instead of 3 minutes for the Time factor. 
Second, an overall analysis was conducted with the baseline, last minute of paced 
breathing, and last minute of recovery with the factors Time (baseline, paced breathing 
min 3, recovery min 3) x Group (PD, EA, NAC) x Condition (HV, HYPO). Comparisons 
were made between PD, EA, and NAC. Furthermore, Raise, Lower, and WL of each 
patient group was compared with each other to test for pre-treatment compatibility. This 
analysis was chosen instead of an analysis of covariance, since we found that the 
assumptions for the latter were violated, yet we wanted to consider changes from baseline 
to paced breathing and recovery.   
 
Change with treatment 
Data collected during the second laboratory assessment were compared to data 
collected the first assessment in an analysis analogous to that of the pre-treatment 
measures with the addition of a factor for progress. Psychological data were analyzed 
with Group (PD, EA, NAC) x Time (baseline, paced breathing, recovery) x Condition 
(HV, HYPO) x Progress (pre-treatment, post-treatment) mixed-effect models. 
Physiological data at baseline were analyzed with Group (PD, EA, NAC) x Condition 
(HV, HYPO) x Progress (pre-treatment, post-treatment) mixed-effect models. During 
paced breathing, Time (min 1, 2, 3) x Group (PD, EA, NAC) x Condition (HV, HYPO) x 
Progress (pre-treatment, post-treatment) models were used. During recovery, analyses 
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were run similar to the paced breathing segment except for using 8 instead of 3 minutes 
for the Time factor. The overall analysis was conducted with the factors Time (baseline, 
paced breathing min 3, recovery min 3) x Group (PD, EA, NAC) x Condition (HV, 
HYPO) x Progress (pre-treatment, post-treatment). Comparisons were made between PD 
Raise, PD Lower, PD WL, EA Raise, EA Lower, EA WL, and NAC. 
 
Effect Size Calculations and Adjustments for Multiple Tests 
To minimize alpha inflation, we considered only a small number of variables to 
be primary measures, namely, those that had distinguished patients and controls in our 
previous study (Wilhelm, Gerlach, & Roth, 2001); remaining measures were considered 
secondary. The following self-report and physiological variables were primary: PDSS, 
EAS, CMQ-anxiety, CMQ-shortness of breath, CMQ-dizziness, CMQ-tingling 
sensations, end-tidal pCO2, HR, VTI, and SCL. For these measures, the criterion for 
statistical significance was p ≤ .05, two-tailed. For the secondary measures the 
probability was set at p < .01, two-tailed.  
 
Effect sizes (ESs) were calculated as Cohen’s d (Cohen, 1988) when appropriate. 
For Group x Progress comparisons, difference scores (e.g., pre- versus post-treatment) 
were computed and means and standard deviations of the differences per group entered 
into Cohen’s equation (d = MGroup A – MGroup B/SDpooled). For all computations, SPSS 15.0 
was used. The criterion for statistical significance was p ≤ .05, two-tailed. 
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RESULTS 
 
Missing Data 
 
For both assessments, 8 PD and 4 EA patients had to be excluded from analysis of 
cardiac measures (HR, RSATF), and one PD patient from analysis of SCL due to 
medications specifically affecting these variables. In addition, because of random data 
loss due to equipment malfunction, slightly lower Ns were used for some analysis. At 
initial assessment, 16 % of RSATF had to be excluded since coherences were lower than 
0.5. Seven (15.6%) PD and three (7.7%) EA patients did not return their questionnaire 
packages. Hence, data on the clinical measures was missing for those subjects. At follow-
up, 9.4% of RSATF had to be excluded due to low coherences. One (5.6%) NAC, 13 
(28.9%) PD, and 3 (7.7%) EA patients did not return their questionnaire packages or 
dropped out.  
 
 
Clinical Measures 
 
PD patients’ total score on the PDSS was 13.6 (see Table 2). In the month prior to 
the initial assessment, they experienced on average 8-9 full-blown panic attacks and 9-10 
limited symptom episodes with severe distress, suffered from moderate anticipatory 
anxiety and agoraphobic fear, and mild fear of panic-related sensations. Overall, they 
were mildly to moderately impaired in work functioning and social life by their disorder. 
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The Episodic Anxiety patients had suffered from 1-2 panic attacks and 16 
expected/unexpected episodic anxiety attacks in the previous month, causing moderate to 
severe distress.  
 
Table 2 
Clinical Measures at Pre-Treatment by Group 
 PD 
(N = 45) 
EA 
(N = 39) 
NAC  
 (N = 20) 
F - ratio p 
Primary measures      
PDSS (0-28) 13.57 (4.21) N/A N/A N/A N/A 
EAS (0-36) N/A 15.36 (3.45) N/A N/A N/A 
Secondary measures      
ASI (0-64) 30.44 (11.11) 23.46 (9.51) 8.50 (5.00) F = 34.70   0.00 
BDI (0-63) 12.53 (7.56) 12.96 (7.75) 2.45 (2.87) F = 17.32 0.00 
MI-AC (0-5) 1.64 (0.57) 1.324 (0.32) 1.10 (0.19) F = 13.33 0.00 
MI-AL (0-5) 2.09 (0.77) 1.61 (0.71) 1.20 (0.70) F = 11.74 0.00 
Note. Values are expressed as means (standard deviations); ASI = Anxiety Sensitivity Index;  
 
BDI = Beck Depression Inventory; EA = Episodic Anxiety; MI = Mobility Inventory for  
 
Agoraphobia (AC = accompanied; AL = alone); NAC = Non-anxious Controls; PD = Panic  
 
Disorder; F values from one-way ANOVAs. 
 
The majority of the Episodic Anxiety patients suffered from full-blown panic 
attacks (66.7%), which is not surprising since Barlow (2002, p.111) had noted that 
limited-symptom attacks rarely occur without a history of full-blown panic attacks. The 
episodic anxiety attacks usually had 3 symptoms and lasted 11-20 minutes. Patients were 
characterized by mild anticipatory anxiety, none to mild agoraphobic avoidance, and mild 
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to moderate impairment in work functioning and social life. Means and standard 
deviations for each item on the PDSS and EAS can be found in the appendix. PD patients 
scored highest on anxiety sensitivity, NAC scored lowest, and EA patients were 
intermediate (see Table 2). Scores on the BDI were equally elevated over controls in both 
patient groups. Agoraphobic avoidance behavior – accompanied or alone – was most 
pronounced in PD and equal in the other two groups. 
 
Panic Disorder Severity Scale
assessment
initial follow-up
(0
-2
8)
0
2
4
6
8
10
12
14
16
18
PD Lower
PD Raise
PD Waitlist
 
Episodic Anxiety Scale
assessment
initial follow-up
(0
-3
6)
0
2
4
6
8
10
12
14
16
18
EA Lower
EA Raise
EA Waitlist
 
 
Figure 1. Means plus standard errors for the Panic Disorder Severity Scale and the Episodic Anxiety Scale 
at pre-treatment and follow-up. 
 
At post-treatment, 6 (50.0%) PD patients in the Lower and 8 (61.5%) in the Raise 
condition no longer met criteria for PD. In the EA groups, 5 (45.5%) patients that 
received treatment with hypocapnic, and 2 (16.7%) of those with hypercapnic breathing, 
no longer met criteria for the diagnosis for which they were enrolled in the study. For 
instance, if an EA patient was enrolled due to experiencing anxiety attacks as part of 
SOP, he/she no longer met criteria for SOP after treatment. In addition, 3 (20%) WL 
patients in the PD and none in the EA group improved from initial to the follow-up 
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assessment. Furthermore, the total PDSS score decreased in the PD Lower and Raise 
groups to 8.12 and 6.71, respectively; EA patients’ score on the EAS decreased to 9.25 in 
the Lower and 8.77 in the Raise group, while both WL groups remained unchanged (see 
Figure 1). In addition, anxiety sensitivity was lower at the follow-up assessment, but was 
not different between treated, waitlisted patients, and NAC. Depression decreased in all 
groups but waitlisted EA patients and NAC. Agoraphobic avoidance behavior did not 
change between assessments. Effect sizes for the primary measures ranged from 1.02 to 
1.63, and for the secondary measures from -0.22 to 1.13. The results of the corresponding 
repeated measures ANOVAs, the effect sizes, and the numbers, means, and standard 
deviations are presented in the appendix. 
 
 
Pre-Treatment Differences between Patients and Non-Anxious Controls 
 
During initial assessment, the NAC increased their pCO2 about 3.9 mm Hg (10.5 
%) from baseline, PD, 3.5 mm Hg (9.9 %), and EA patients, 1.81 mm Hg (5.0 %). During 
the VHT, the NAC decreased their pCO2 14.6 mm Hg (39.6 %) to 22.3 mm Hg. PD 
patients reached 22.8 mm Hg (decrease of 13.7 mm Hg; 37.6 %) and EA patients        
21.0 mm Hg (decrease of 14.2 mm Hg; 40.3 %). In neither test, was there a difference in 
change between groups (VHO: F[6,1186] = 1.26, p = 0.29; VHT: F[6,5.58] = 0.61, p = 
0.72). Furthermore, there was no difference in the ambient temperature in the laboratory 
between groups, F(6,8.26) = 1.12 , p = 0.36. 
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During initial assessment, none of the NAC, 2 (6.5%) PD, and 3 (8.6%) EA 
patients experienced a panic attack during the VHO; 1 (5.6%) NAC, 7 (22.6%) PD, and 4 
(12.9%) EA patients panicked during the VHT. The differences were not significant 
(HYPO: χ2[6] = 5.78, p = 0.45; HV: χ2[6] = 6.04, p = 0.47). Furthermore, there was a 
trend towards NAC and PD patients finding the VHO more difficult than the VHT, and 
EA patients finding the VHT more challenging. On the other hand, there was a trend 
towards more NAC and PD patients finding the VHT unpleasant; and EA patients finding 
the VHO causing more discomfort. These differences were also not significant 
(difficulty: χ2[12] = 16.93, p = 0.15; discomfort: χ2[12] = 18.02, p = 0.12). The results of 
the corresponding chi-square tests are presented in the appendix.  
 
Comparison of the baseline, last minute of paced breathing, and last minute of 
recovery showed that patients overall were more anxious, F(2,118.12) = 6.90, p = 001, 
distressed, F(2, 127.94) = 7.63, p = 0.001, tense, F(2, 119.85) = 9.20, p = 0.00, worried, 
F(2, 113.88) = 4.49, p = 0.13 , less relaxed, F(2, 115.56) = 9.16, p = 0.00, and felt more 
dizziness, F(2, 146.07) = 5.49, p = 0.05, chest pain, F(2, 140.72) = 3.76, p = 0.03, and 
nausea, F(2, 108.05) = 3.21, p = 0.04, than NAC. There were no differences between 
groups in shortness of breath, F(2, 151.90) = 2.17, p = 0.12, tingling, F(2, 137.73) = 0.82, 
p = 0.44, heart racing, F(2, 140.59) = 2.32, p = 0.10, sweating, F(2, 153.36) = 1.13, p = 
0.33, trembling, F(2, 161.01) = 1.42, p = 0.25, chills, F(2, 134.69) = 2.02, p = 0.14, fear 
of losing control, F(2, 15.48) = 0.38, p = 0.68, fear of dying, F(2, 139.79) = 0.73, p = 
0.73, or depersonalization/derealization, F(2, 126.53) = 1.06, p = 0.35. We found Time 
effects for all items on the CMQ, with the following increasing during the paced 
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breathing segments and decreasing with recovery in all groups: Anxiety, F(2, 333.79) = 
58.16, p = 0.00, shortness of breath, F(2, 330.24) = 82.60, p = 0.00, dizziness,             
F(2, 324.02) = 54.79, p = 0.00, tingling, F(2, 320.68) = 9.54, p = 0.00, heart racing,     
F(2, 35.72) = 53.01, p = 0.00, sweating, F(2, 334.74) = 8.75, p = 0.00, trembling,        
F(2, 330.91) = 5.23, p = 0.006, chest pain, F(2, 341.83) = 10.64, p = 0.00, nausea,       
F(2, 363.79) = 4.38, p = 0.013, fear of losing control, F(2, 331.93) = 18.67, p = 0.00, 
chills, F(2, 323.61) = 3.09, p = 0.047, fear of dying, F(2, 337.84) = 13.45, p = 0.00, 
distress, F(2, 340.97) = 53.86, p = 0.00, depersonalization/derealization, F(2, 335.05) = 
13.41, p = 0.00, tension, F(2,  338.58) = 69.91, p = 0.00, and worry, F(2, 343.90) = 
24.96, p = 0.00. Relaxation, F(2, 319.46) = 114.61, p = 0.00, showed the opposite effect. 
Overall, dizziness, F(1, 295.71) = 8.11, p = 0.005, and tingling, F(1, 293.37) = 5.66, p = 
0.02, were higher during the VHT than the VHO. Anxiety, F(2, 360.53) = 3.51, p = 0.03, 
dizziness, F(2, 358.72) = 7.28, p = 0.001, heart racing, F(2, 366.61) = 3.19, p = 0.04, and 
nausea, F(2, 366.00) = 3.58, p = 0.03, increased more from baseline to HV than HYPO. 
Furthermore, relaxation, F(4, 319.53) = 2.53, p = 0.04, fell more during the paced 
breathing in NAC than in patients in either test. This effect was due to higher levels in the 
controls to begin with. We found one Group x Time x Condition interaction for nausea, 
F(4, 366.09) = 3.88, p = 0.004, which was due to a greater increase in PD patients during 
HV than in EA patients or the NAC. We did not find any Group x Condition interactions. 
The results of the corresponding mixed-effects models and the numbers, means, and 
standard deviations are presented in the appendix. Figure 2 depicts ratings on anxiety, 
dizziness, shortness of breath, and tingling. 
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Figure 2. Means plus standard errors for anxiety, dizziness, shortness of breath, and tingling during the 
Voluntary Hypoventilation and Hyperventilation Test (randomized order; at baseline [b], paced breathing 
[h], and recovery [r]) in Panic Disorder patients, Episodic Anxiety patients, and non-anxious controls at 
pre-treatment. 
 
At baseline, pCO2 levels were lower in both conditions before HYPO across all 
groups, F(1,80.24) = 6.92, p = 0.01, with the greatest difference in the PD patients 
compared to EA patients and the NAC, F(2,80.27) = 2.25, p = 0.04 (see Figure 2). RR 
was highest in PD, F(2,78.27) = 6.49, p = 0.002, and overall higher before HV than 
HYPO, F(1,74.98) = 5.75, p = 0.02, which was due to higher values in the NAC, 
F(2,75.00) = 5.23, p = 0.007. Two respiratory measures, VTI, F(2,73.92) = 4.32, p = 
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0.02, and number of sighs, F(2,78.81) = 5.14, p = 0.008, were higher in PD than EA and 
NAC. VT on the other hand, was equally higher in PD and NAC than in EA, F(2,71.79) 
= 3.94, p = 0.02. We also found differences between the VHT and VHO: SCL, 
F(1,72.00) = 4.99, p = 0.03, and NSF were higher, F(1,75.01) = 12.73, p = 0.001, before 
HYPO compared to HV. There were no effects for RRI or the cardiac measures. During 
paced breathing, all physiological measures were different between tests, the following 
being higher: pCO2, F(1,477.52) = 1572.92, p = 0.00, sighs, F(1,278.28) = 87.63, p = 
0.00, and RSATF, F(1,325.94) = 96.23, p = 0.00, were lower during HV than HYPO; VT, 
F(1,430.69) = 307.33, p = 0.00, VTI, F(1,382.53) = 43.53, p = 0.00, RR, F(1,203.67) = 
30534.03, p = 0.00, RRI, F(1,340.92) = 43.55, p = 0.00, HR, F(1,389.09) = 111.72, p = 
0.00, SCL, F(1,407.30) = 5.30, p = 0.03, and NSF F(1,447.54) = 30.09, p =0.00. pCO2 
showed a Time effect, F(2,412.24) = 16.24, p = 0.00, and a Time x Condition interaction, 
F(2,382.38) = 82.28, p = 0.00,: it decreased during HV and increased during HYPO in all 
groups. Other Time effects included fewer sighs, F(2,306.69) = 4.73, p = 0.01, and fewer 
NSFs, F(2,394.21) = 12.51, p = 0.00, and increasing VT, F(2,360.14) = 4.31, p = 0.014, 
and HR, F(2,352.14) = 63.60, p = 0.00, from minute 1 to 3 of the paced breathing 
segments. RRI was lower in the PD patients than both other groups, Group effect 
F(2,101.60) = 3.37, p = 0.04. RR showed a Group x Time x Condition interaction, 
F(4,227.43) = 3.71, p = 0.006, that was explained by slower breathing in the NAC during 
the first minute of HV. Moreover, VT was higher during HV than HYPO across all 
groups and lower in PD during HV than the other two groups; it also increased more 
during HV than HYPO (Group x Condition: F[2,430.65] = 7.63, p = 0.001; Time x 
Condition: F[2,333.84] = 4.76, p = 0.009). HR rose more in EA than PD or NAC from 
 40
Psychophysiological Effects of Breathing Training in Panic Disorder and Episodic Anxiety  
 
minute 1 to 3 and overall more during HV than HYPO (Group x Time: F[4,352.14] = 
2.74, p = 0.03; Time x Condition: F[2,328.60] = 14.37, p = 0.00). SCL showed in a Time 
x Condition interaction due to a fall during HYPO and a rise during HV. The Group x 
Time x Condition interaction for number of sighs, F(4,339.52) = 3.81, p = 0.005, was due 
to different changes in the groups over time: during HYPO, NAC and PD had fewer sighs 
during minute 2 compared to minute 1 and 3, while EA patients showed the opposite; and 
at the end of the HV segment, EA and NAC had fewer, and PD more, sighs. During 
recovery, pCO2, F(7,1129.66) = 57.37, p = 0.00, RR, F(7,1033.32) = 3.26, p = 0.002, and 
RSATF, F(7,775.19) = 3.37, p = 0.002, rose; VT, F(7,964.44) = 13.93, p = 0.00, VTI, 
F(7,823.41) = 10.48, p = 0.00, HR, F(7,1027.35) = 14.92, p = 0.00, sighs, F(7,772.33) = 
15.90, p = 0.00, SCL, F(7,1048.78) = 54.11, p = 0.00, and NSF, F(7,896.52) = 32.66, p = 
0.00, fell with time in all groups (see Figure 2). End-tidal pCO2, F(1,831.03) = 144.80, p 
= 0.00, RR, F(1,416.58) = 5.80, p = 0.02, and NSF, F(1,248.06) = 7.23, p = 0.008, were 
higher. RRI, F(1,292.18) = 4.13, p = 0.04, was lower during recovery from HYPO than 
HV. RR was the only measure that was different between groups, being lowest in the EA 
patients and equal in the two other groups, F(2,109.75) = 3.66, p = 0.003. We found two 
Time x Condition interactions:  pCO2, F(7,1157.71) = 24.65, p = 0.00, rose and HR, 
F(7,1028.53) = 5.18, p = 0.00, fell more during recovery from HV than HYPO. 
Furthermore, VTI, F(14,835.48) = 2.07, p = 0.012, and number of sighs, F(14,772.80) = 
4.03, p = 0.00, showed a greater decrease in PD than EA patients and the NAC during 
recovery; RRI, F(14,950.29) = 2.60, p = 0.001, increased mildly in the controls but not 
the patients. We found neither Group effects, nor Group x Condition or Group x Time x 
Condition interactions. The results of the corresponding mixed-effects models and the 
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numbers, means, and standard deviations are presented in the appendix. Figure 3 depicts 
the end-tidal pCO2 and heart rate during both tests. 
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Figure 3. Means plus standard errors for end-tidal pCO2 and heart rate during the Voluntary 
Hypoventilation and Hyperventilation Test (randomized order; at baseline [b], 3 min paced breathing [h], 
and 8 min recovery [r]) in Panic Disorder patients, Episodic Anxiety patients, and non-anxious controls at 
pre-treatment. 
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The overall analysis showed that PD patients had the highest RR, EA the lowest, 
and NAC was intermediate, F(2,114.74) = 6.94, p = 0.001. Number of sighs was also 
higher in the PD over both other groups, F(2,159.71) = 5.25, p = 0.006. Across both tests, 
HR, F(2,358.38) = 87.34, p = 0.00, VT, F(2,306.80) = 51.69, p = 0.00, VTI, F(2,264.68) 
= 5.63, p = 0.004, SCL, F(2,360.94) = 141.00, p = 0.00, and NSF, F(2,332.30) = 70.32,   
p = 0.00, rose with paced breathing and fell with recovery; CO2, F(2,386.78) = 423.26,   
p = 0.00, RR, F(2,269.22) = 10.00, p = 0.00, and RRI, F(2,242.42) = 64.02, p = 0.00, fell 
with the second segment and rose again with recovery. We found some differences 
between conditions: pCO2, F(1,441.56) = 254.32, p = 0.00, RSATF, F(1,257.82) = 11.35, 
p = 0.001, and sighs, F(1,275.73) = 5.99, p = 0.02, were overall higher and RR, 
F(1,261.45) = 189.92, p = 0.00, VT, F(1,308.00) = 55.97, p = 0.00, and HR, F(1,417.95) 
= 7.64, p = 0.006, were lower during the VHO than the VHT. Several significant Time x 
Condition interactions occurred: the interaction for pCO2, F(2,366.45) = 1040.24, p = 
0.00, and sighs, F(2,341.28) = 17.46, p = 0.00, were due to lower levels during HV but 
higher levels during HYPO compared to its baselines and recoveries. RSATF, F(2,290.70) 
= 24.28, p = 0.00, RR, F(2,324.76) = 284.78, p = 0.00, VT, F(2,37.86) = 125.77, p = 
0.00, VTI, F(2,308.67) = 5.47, p = 0.005, and HR, F(2,331.16) = 79.43, p = 0.00, showed 
exactly the opposite effect: they decreased from baseline to HYPO and increased to HV.  
SCL, F(2,334.06) = 9.43, p = 0.00, and NSFs, F(2,366.15) = 15.33, p = 0.00, rose more 
from baseline to HV than to HYPO. Furthermore, RR, F(4,269.64) = 3.84, p = 0.005, and 
VTI, F(4,265.01) = 5.90, p = 0.00, changed more in PD than in EA or NAC. 
HR,F(4,358.48) = 3.11, p = 0.02, changed more in the two patient groups, while VT, 
F(4,307.01) = 3.91, p = 0.004, changed least in PD from baseline, last minute of paced 
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breathing, to the last minute of recovery. The overall analyses did not yield any Group x 
Condition interactions. The results of the corresponding mixed-effects models and the 
numbers, means, and standard deviations are presented in the appendix.  
 
 
Pre-Treatment Differences between Raise, Lower, and Waitlist Patients 
 
At initial assessment, PD patient treatment groups did not differ on demographic 
variables or any of the clinical measures. During the psychophysiological assessment, 
patients in the Lower condition feared losing control less than the other two groups, 
F(2,59.38) = 3.14, p = 0.05. The WL on the other hand felt least relaxed, F(2,46.57) = 
4.48, p = 0.02. Fear of dying, F(4,151.78) = 2.84, p = 0.03, increased more in the WL and 
Lower during paced breathing than in the Raise group. The Group x Time x Condition 
interaction for trembling, F(4,152.83) = 2.99, p = 0.02, was explained by a greater rise in 
the WL during HYPO and less during HV than the other two groups.  
 
For the physiological measures, there were few effects. RR and RRI showed main 
effects and interactions. Effects for RR (baseline: Group, F(2,30.40) = 3.22, p = 0.05; 
paced breathing: Group, F(2,47.80) = 4.46, p = 0.02, Group x Time, F(4,95.50) = 2.83,   
p = 0.03, Group x Time x Condition, F(4,107.76) = 3.23, p = 0.02; overall: Group, 
F(2,40.75) = 4.66, p = 0.02, Group x Time, F(4,109.27) = 6.43, p = 0.00) were explained 
by highest values in the Lower group that fell more during HYPO and rose less during 
HV. RRI was highest during the VHO baseline and lowest during the VHT baseline in 
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the Raise group but consistently higher during the paced breathing segments with the 
greatest values during the first minutes (baseline: Group x Condition, F(2,24.83) = 3.53, 
p = 0.05; paced breathing: Group, F(2,30.23) = 9.82, p = 0.001, Group x Time, 
F(4,91.31) = 3.97, p = 0.005; overall: Group x Time x Condition, F(4,113.57) = 2.69, p = 
0.03). Furthermore, VT was highest during HV in the WL, F(2,146.28) = 3.34, p = 0.04, 
and NSF, F(2,61.38) = 3.77, p = 0.03, was lowest in the Raise group during recovery 
which also caused the Group x Time interaction in the overall analysis, F(4,109.07) = 
2.57, p = 0.04. VTI was highest in the WL at the VHO baseline and highest in the Lower 
group at VHT baseline, F(2,27.50) = 3.50, p = 0.04. During the paced breathing, VT 
increased across both conditions only in the Raise group, F(2,146.28) = 3.34, p = 0.04. 
The results of the corresponding mixed-effects models and the numbers, means, and 
standard deviations are presented in the appendix.  
 
EA patients were matched on most demographic and clinical measures. However, 
the WL had higher scores on the ASI than both immediate treatment groups, F(2,559.60) 
= 9.15, p = 0.001, and the Lower group had lower scores on the BDI than the WL, 
however, Lower and WL were both not different from Raise, F(2,218.74) = 4.39, p = 
0.02. During the psychophysiological assessment, the WL scored overall higher on 
anxiety, F(2,53.92) = 4.15, p = 0.02, tingling, F(2,72.48) = 5.36, p = 0.01, and chills, 
F(2,72.23) = 4.26, p = 0.02.  
 
Among physiological measures, we found five interactions (Group x Time for 
RR, Group x Condition and Time x Condition for RRI, Group x Condition for VTI, 
Group x Time x Condition for sighs) during the paced breathing segments: RR, 
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F(4,100.90) = 4.99, p = 0.001, was slightly higher in the Lower group during minute 2 of 
HYPO; RRI was in general lower in the WL during HYPO than HV, F(1,150.89) = 
10.29, p = 0.002, and also slightly rose during minute 2, F(2,150.91) = 3.35, p = 0.04; 
VTI, F(2,167.34) = 3.58, p = 0.03, was higher in the Raise group during HV; number of 
sighs increased more during minute 2 of HYPO in the WL than the other two groups or 
HV, F(4,147.00) = 2.58, p = 0.04. During recovery, VTI showed a greater decline in the 
Raise group during recovery from HYPO than in the other two groups and compared to 
the VHT, F(4,141.30) = 2.49, p = 0.05. RRI declined slightly in the Lower and increased 
in the Raise group over time, F(2,150.91) = 3.35, p = 0.04, and in general greater changes 
took place in RRI during recovery from HV than HYPO, F(4,141.30) = 2.49, p = 0.05. 
Furthermore, NSF declined more in the Lower group, F(14,279.71) = 2.78, p = 0.001. 
There were four Group x Time interactions involving the baseline, the last minute of 
paced breathing, and the last minute of recovery. From baseline to paced breathing, HR 
F(4,160.21) = 6.37, p = 0.00, increased less in the WL;  RR, F(4,109.17) = 3.76, p = 
0.01, increased more in the Lower group; and pCO2, F(4,163.87) = 4.88, p = 0.001, 
increased more in the Raise group.   
 
 
Pre-Treatment Differences between Completers and Drop-outs  
 
There were no differences between PD completers and drop-outs in the 
demographic data, clinical outcome, or psychometric measures. On physiological 
measures during recovery, drop-outs compared to completers had higher pCO2 levels, 
F(1,35.82) = 6.11, p = 0.02, VTI, F(1,54.86) = 4.83, p = 0.03, more sighs, F(1,116.31) = 
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8.33, p = 0.005, and fewer NSF, F(1,61.43) = 7.24, p = 0.01, . The overall analysis also 
confirmed the higher pCO2 levels, F(1,36.11) = 4.71, p = 0.04, and fewer NSFs, 
F(1,55.52) = 7.15, p = 0.01, in the drop-outs. Among the EA patients, there was only one 
drop-out who was part of the psychophysiological analysis. Hence, no comparison 
between completers and drop-outs were made. The results of the corresponding mixed-
effects models and the numbers, means, and standard deviations for the PD patients are 
presented in the appendix.  
 
 
Psychophysiological Change with Treatment 
 
At the follow-up assessment, the following pCO2 increases from baseline were 
observed during HYPO: NAC 4.2 %; PD Lower 5.5%, PD Raise 12.3%, PD WL 0.7%, 
EA Lower 12.4%, EA Raise 7.0%, and EA WL 5.1%. During HV, NAC lowered their 
pCO2 42.0%, PD Lower 38.7%, PD Raise 35.4%, PD Waitlist 39.2%, EA Lower 33.0%, 
EA Raise 39.2%, and EA WL 40.1%. The mixed-effect models showed that the change 
rates were different between groups, F(12,789.17) = 1.78, p = 0.05. There was no 
difference in the ambient temperature in the laboratory, F(6,265.04) = 0.99 , p = 0.44. 
 
None of the NAC or PD patients, and 2 (6.3%) EA patients experienced a panic 
attack during the VHO; none of the controls or EA patients, and 5 (16.1%) PD patients 
panicked during the VHT. The differences were not significant (HYPO: χ2[6] = 2.82, p = 
0.83; HV: χ2[6] = 9.95, p = 0.13). Furthermore, ratings on difficulty and discomfort of 
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both tests were not different between groups, χ2(12) = 13.30, p = 0.35. The results of the 
corresponding Chi-Square Tests are presented in the appendix.  
 
For psychological variables, we found several effects for the factor Progress: 
anxiety, F(1,326.88) = 13.38, p = 0.00, tension, F(1,335.94) = 10.34, p = 0.001, worry, 
F(1,326.84) = 4.29, p = 0.04, shortness of breath, F(1,376.89) = 3.82, p = 0.05, chest 
pain, F(1,335.09) = 3.74, and heart racing, F(1,362.78) = 8.93, p = 0.003, were lower at 
follow-up compared to the initial assessment in all groups. Furthermore, shortness of 
breath, F(2,785.79) = 3.13, p = 0.04, heart racing, F(2,795.06) = 6.77, p = 0.001, and 
chest pain, F(2,829.65) = 3.21, p = 0.04, increased less from baseline to the paced 
breathing at follow-up, regardless of the condition or group. Sweating increased less at 
follow-up in the immediate treatment groups, F(12,778.32) = 1.80, p = 0.04. Trembling 
was higher during HYPO at follow-up in the NAC, PD Lower, and PD WL,  and higher 
during HV at follow-up in the NAC and PD WL; the EA patients did not change on that 
item, F(12,816.62) = 2.70, p = 0.001. The results of the corresponding mixed-effects 
models and the numbers, means, and standard deviations are presented in the appendix.  
 
At baseline, pCO2 was lower in both Lower patient groups (decreased in PD 
2.31%, in EA 6.02%) and from initial to follow-up increased in both Raise patient groups 
(increase in PD 5.11%, in EA 4.51%) and remained unchanged in the WL groups and 
NAC, F(6,289.88) = 5.49. SCL showed a Progress effect, F(1,200.91) = 9.23, p = 0.003, 
due to lower levels at follow-up, a Condition x Progress interaction due to a decrease 
from initial assessment to follow-up across all groups before HYPO but not before HV, 
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F(1,145.87) = 6.03, p = 0.02, and a Group x Progress interaction due to lower levels at 
follow-up in PD Lower, PD Raise, EA Lower, and EA WL, F(6,632.24) = 3.49, p = 
0.005. NSFs were also fewer at follow-up before HYPO than HV, F(1,222.86) = 4.51,    
p = 0.04. VT decreased in the NAC and all PD but increased in all EA patients from 
initial to follow-up, F(6,294.18) = 3.49, p = 0.002. RSATF fell from the first to the second 
evaluation in both PD immediate treatment groups and the EA WL, and rose in the EA 
Raise and PD WL, F(6,252.41) = 2.46, p = 0.03. During paced breathing, pCO2 was 
lower in both Lower and higher in both Raise groups, F(6,386.05) = 2.99, p = 0.007 . VTI 
showed a Time x Progress interaction, F(2,754.81) = 4.79, p = 0.009, and a Condition x 
Progress, F(1,689.54) = 5.46, p = 0.02, interaction. The first interaction was due to a 
decrease at minute two of the paced breathing at follow-up but not initial assessment and 
the latter to a general rise during HYPO but no change during HV from initial to follow-
up. Values for RR changed slightly to the second assessment, F(12,585.40) = 2.76, p = 
0.001:  there were higher levels for PD Lower at min 3 of HYPO and min 1 of HV as well 
as for EA Lower at min 3 of HV, and lower levels for PD Raise at min 1 and 2 of HV, 
and for EA Raise at min 3 of HYPO. From the first to the second evaluation, RRI 
decreased during HYPO in the NAC, PD Raise, and EA Lower and even increased in the 
EA WL; during HV it was higher in both PD immediate treatment groups (Condition x 
Progress: F[1,497.59] = 5.48, p = 0.02; Group x Condition x Progress: F[6.497.17] = 
3.43, p = 0.003). The Time x Progress interaction for sighs was explained by a steady 
decrease over time at follow-up, but an increase in minute 3 of the paced breathing at 
initial assessment, F(2,664.35) = 5.90, p = 0.003. Furthermore, sighs changed from the 
first to the second assessment during HYPO: they increased in both Lower groups and the 
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NAC, and decreased in both Raise groups (Group x Time x Progress: F[12,663.12] = 
2.36, p = 0.006; Time x Condition x Progress: F[2,699.81] = 6.00, p = 0.003 ; Group x 
Time x Condition x Progress: F[12,698.36] = 2.71, p = 0.001). SCL was overall lower at 
follow-up, F(1,632.10) = 13.80, p = 0.00, which was caused by lower values only in both 
immediate PD patient groups, EA Lower, and EA WL, F(6,632.24) = 3.49, p = 0.005. 
During recovery, both Lower groups had lower and both Raise groups higher pCO2 levels 
at follow-up compared to initial assessment, F(6,409.94) = 3.42, p = 0.003. SCL on the 
other hand was lower at follow-up in the NAC, PD Raise, and EA WL groups but higher 
in PD Lower, EA Lower, and EA Raise, F(6,576.33) = 2.54, p = 0.02. VT showed a 
smaller decrease over time during recovery from HYPO at the follow-up compared to 
initial and was overall lower, F(7,1979.03) = 2.22, p = 0.03. RRI was also lower at 
follow-up across all groups, F(1,349.29) = 11.04, p = 0.001. The last respiratory measure 
that yielded significant results was number of sighs with a Group x Time x Condition x 
Progress interaction, F(42,1618.55) = 1.61, p = 0.008: sighs changed less over time at 
follow-up compared to initial and were increased during recovery from HYPO at follow-
up in all groups but both the two patient groups that received hypercapnic treatment, who 
had fewer sighs; recovery from HV showed the opposite effect for the groups (more in 
both Raise, fewer in all other groups). NSFs increased during follow-up in all groups, 
F(1,222.86) = 4.51, p = 0.04. Looking at the groups separately, PD Lower, PD WL, and 
both EA treatment groups had more NSF at follow-up; all other groups (NAC, PD Raise, 
EA WL) had fewer, F(6,222.05) = 2.47, p = 0.03. ESs for the change of resting pCO2 
levels in the immediate treatment groups vs. waitlisted patients ranged from -0.69 to 0.54. 
The results of the corresponding mixed-effects models, effect sizes, and the numbers, 
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means, and standard deviations are presented in the appendix. Figure 4 displays the end-
tidal pCO2 levels for both tests at initial assessment and follow-up. 
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Follow-Up 
 
Figure 4. Means plus standard errors for end-tidal pCO2 during the Voluntary Hypoventilation and 
Hyperventilation Test (randomized order; at baseline [b], 3 min paced breathing [h], and 8 min recovery 
[r]) in Panic Disorder patients, Episodic Anxiety patients, and non-anxious controls at pre-treatment and 
follow-up. 
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Overall analysis yielded significant results for two primary and two secondary 
measures. End-tidal pCO2 decreased after treatment in both Lower groups and increased 
in both Raise groups; the WL and NAC did not change, F(6,314.78) = 2.86, p = 0.01. 
Furthermore, increase from baseline to HYPO was greater in the PD Raise and EA Lower 
groups, and less in PD Lower, PD WL, EA Raise, and NAC at the follow-up. Change 
from baseline to HV was smaller in PD Raise, EA Raise, and EA Lower, and greater in 
PD Lower, PD WL, and NAC, F(12,789.17) = 1.78, p = 0.05. Sighs were more frequent 
at follow-up than at initial assessment except for EA Raise during VHO, and more 
frequent during HYPO and less  frequent during HV than its baselines and recoveries 
except for PD Raise (also had more sighs during HV than baseline and recovery) and EA 
Raise (had fewer sighs during HYPO), F(12,718.73) = 2.35, p = 0.006. SCL showed a 
Condition x Progress interaction, F(1,622.84) = 4.34, p = 0.04, explained by a greater 
increase from initial to follow-up in the VHT than VHO. NSF were overall fewer in PD 
Lower, PD WL, EA Lower, and EA Raise at follow-up and more frequent in the NAC, 
PD Raise, and EA WL, and showed the greatest increase from baseline to paced 
breathing in the EA Raise group during the VHT, F(12,506.07) = 1.81, p = 0.04. The 
results of the corresponding mixed-effects models and the numbers, means, and standard 
deviations are presented in the appendix. 
 
The completer analysis had similar results but on higher significance levels. The 
results of the mixed-effects models and the numbers, means, and standard deviations are 
presented in the appendix. 
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DISCUSSION 
 
The aim of this study was to investigate whether patients suffering from Panic 
Disorder or Episodic Anxiety would exhibit a greater psychophysiological response than 
non-anxious controls to two respiratory challenges, namely, voluntary hypoventilation 
and hyperventilation, and whether breathing training would attenuate these responses. 
These questions are important since PD has been considered a disorder with prominent 
respiratory abnormalities and therefore, treatment targeted at changing these 
abnormalities should influence the reaction to respiratory challenges. In addition, there is 
evidence that reactions to provocations may be more related to whether an individual has 
had a panic attack than to whether he or she meets the full criteria for PD. Hence, patients 
who are suffering from anxiety attacks might benefit from treatment with BT, regardless 
of their diagnosis.  
 
 
Effects of Voluntary Hypoventilation and Hyperventilation 
 
Voluntary hypoventilation and hyperventilation affected most self-report and 
physiological measures of both patient groups and NAC. Moreover, most self-reported 
variables were changed equally by the two test provocations. Both, HYPO and HV 
increased fear of dying, tension, worry, fear of losing control, overall distress, and 
sensations of shortness of breath, heart racing, sweating, trembling, chest pain, nausea, 
chills/hot flashes, and during both tests people felt less relaxed than at baseline or 
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recovery. However, overbreathing resulted in greater reports of dizziness and tingling and 
of a greater increase in dizziness from baseline compared to underbreathing. Anxiety 
increased in both conditions, but more from baseline to HV than from baseline to HYPO. 
PD patients showed a trend towards more anxiety during HV than the other two groups, 
but the three-way interaction was not significant. Furthermore, neither test was perceived 
as being more difficult to perform or causing more discomfort than the other, and neither 
provoked more panic attacks.   
 
As expected, we found several differences between the effects of the VHO and 
VHT on physiological measures during the paced breathing segment. Not surprisingly, 
pCO2 was different since different goals for changing it had been given to our patients. 
All respiratory (pCO2, VT, VTI, RR, RRI, sighs) and activation measures (HR, RSATF, 
SCL) were different. Tidal volume, VTI, RR, RRI, HR, and SCL were higher; pCO2, 
sighs, and RSATF, were lower during overbreathing compared to underbreathing. In order 
to achieve the required rise or drop in pCO2, breathing depth and rate were lowered 
during HYPO and increased during HV. Other findings such as higher HR during 
overbreathing may have been caused by greater physical exertion and disturbance of the 
respiratory system, seen in higher VTI and RRI. This is consistent with numerous studies 
showing that HV causes an increase in HR regardless of diagnosis (Asmundson et al., 
1994; Rutherford et al., 2005; Todd et al., 1995; Whittal et a., 1995). Changes in pCO2, 
VT, HR, and SCL over the 3 minutes were greater during HV than HYPO. On the other 
hand, RSATF, an indicator of parasympathetic activation, was higher during HYPO. 
These findings go along with Asmundson et al.’s (1994) and Fiamma et al’s (2007) 
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findings, two studies that directly compared HYPO and HV. The authors found that HV 
increased HR and breathing variability and attenuated RSATF, whereas HYPO augmented 
RSATF and even decreased HR and breathing variability. During recovery, deactivation 
was seen in both conditions: HR, RSATF, SCL, and NSF decreased over time. Not 
surprisingly, we found higher pCO2 during the VHO recovery since baseline levels were 
achieved quicker than during the VHT. Since both pCO2 and HR changed more during 
HV than HYPO, these measures also increased and declined, respectively, more during 
recovery from HV than from HYPO. Furthermore, RR rose and VT, VTI, and sighs fell 
with time, regardless of the condition. Since subjects were breathing very deeply during 
HV, it is not surprising that we observed fewer sighs than during underbreathing, when 
people were more likely to gasp for air because of lack of oxygen and a sigh could have 
been detected more easily with our algorithm (a sigh was defined as a breath twice the 
normal size). Neither result can be explained by pre-existing differences between both 
conditions.  
 
Greater changes in physiological measures appeared only in overall greater 
dizziness and tingling during the VHT compared to VHO, and in no other self-report 
measures. Since baseline anxiety was the same for both tests, it is unlikely that the 
instruction of having to hypo- or hyperventilate caused different levels of anxiety and in 
turn produced different effects on physiological measures. Hence, the physiological 
symptoms themselves may have caused the anxiety. On the other hand, it is possible that 
the sensation of dizziness was sufficient to create a fear of fainting, which could have 
accounted for increase anxiety.   
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Direct comparison of HYPO and HV produced by voluntary changes of breathing 
has hardly been reported previously. Our results suggest that HYPO and HV without 
changing the composition of inhaled gases to change pCO2 levels, result in different 
physiological effects during the altered breathing itself. The lower pCO2 during recovery 
from HV is probably simply due to the smaller preceding change with HYPO.  
 
 
Reaction to Respiratory Challenges 
 
Our findings confirmed some of our previous results of baseline respiratory 
abnormalities in PD, but our pre-treatment analysis did not support our hypothesis that 
PD and EA patients would show a stronger psychophysiological reaction to both tests 
than non-anxious controls. 
 
At baseline, both patient groups felt equally more anxious, distressed, tense, 
worried, and less relaxed than the NAC. With our design, we cannot address the cause of 
the elevated levels of anxiety before the tests. They may represent baseline anxiety (tonic 
arousal) or anticipatory anxiety. Of physiological measures, pCO2 was higher before 
hyperventilating, which was caused by increased baseline levels in the PD patients. Since 
the two tests were given in an order randomized across subjects, this cannot be due to 
carry over effects from the previous challenge. Since a drop in pCO2 is caused by an 
increase in VT and/or RR, we would have expected these differences also to be present in 
the PD patients. Surprisingly, VT and RR were not lower before HV. Nevertheless, some 
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people may have done one or the other, i.e. changed either VT or RR, which could have 
overwhelmed the overall Group x Condition interaction. Furthermore, baseline anxiety 
was not different in PD between tests. Hence, lower pCO2 could have not represented 
anticipatory anxiety before underbreathing. With our recorded data we cannot explain 
why PD patients had a lower resting pCO2 before HYPO.  
 
In both conditions, RR, VTI, and number of sighs differed between groups. These 
3 measures were all greater in PD than EA patients or the NAC, which confirms findings 
of numerous other studies showing faster breathing and breathing instability in PD under 
resting conditions. However, the usually associated lower pCO2 was not observed, 
possibly because the differences in RR between groups were not great enough. In the 
NAC, breathing was faster before HV than HYPO. It is unlikely that this represented 
anticipatory anxiety, since self-reported anxiety was not different between conditions. 
SCL and number of NSFs were higher before HYPO than HV across all groups, which 
was not accompanied by more self-reported sweating or anxiety. This may have been 
caused by mechanisms unrelated to the testing procedure. 
 
All self-reported3 variables collected during the laboratory procedures increased 
from baseline to paced breathing and decreased again during recovery except for 
relaxation, which was lowest during the paced breathing segments, and chills/hot flashes, 
which did not change at all. All groups felt more anxious, tense, worried, distressed, 
dizzy, short of breath, sweaty, nauseated, and experienced greater fear of losing control, 
                                                 
3 Time effects, Condition effects, and Time x Condition effects were described above (section “Effects of 
Voluntary Hypoventilation and Hyperventilation” and therefore omitted from this paragraph. 
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fear of dying, depersonalization/derealization, tingling, heart racing, trembling, and chest 
pain during the paced breathing than at baseline or recovery. In addition, anxiety and 
dizziness increased more during HV than HYPO, and tingling was overall higher during 
the VHT. Only nausea increased more in PD patients from baseline to HV compared to 
the EA patients and NAC. Otherwise, no Group differences were found. Both patient 
groups had tonically higher ratings on few items but reactivity to the tests was equivalent 
to controls in that we did not find any Group x Time interactions. Furthermore, the 
frequency of panic attacks elicited by over- and underbreathing as well as subjects’ 
comparison of the two tests in terms of difficulty and discomfort was not different 
between groups. These findings go along with several studies that have shown that 
respiratory challenges also increase anxiety in healthy controls, even though generally 
less than in patients (e.g., Rapee, Brown, Antony, & Barlow, 1992; Roth, Wilhelm, & 
Trabert, 1998; Thyer, Papsdorf, & Wright, 1984; Wilhelm, Gerlach, & Roth, 2001). 
Moreover, Margraf et al. (Margraf, Ehlers, & Roth 1986) showed that after baseline 
differences are accounted for, the increase in anxiety was the same in PD and NAC. In 
our study, symptom report during HV and HYPO was associated with a change in pCO2 
but unrelated to group membership. 
 
Physiological measures were equivalent in all groups during the paced breathing 
segments of the VHO and VHT. However, from minute 1 to 3, some primary and 
secondary variables changed. For instance, pCO2 increased during HYPO and decreased 
during HV, respectively, over the entire three minutes of paced breathing. Heart rate and 
VT increased more over time during HV. HR furthermore changed more in EA patients 
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than the other two groups due to lower baseline levels, although the baseline differences 
did not reach significance. Tidal volume was lower in PD during HV. This result is most 
likely due to the greater RR the PD group had to begin with, which made it unnecessary 
to increase the VT so much to reach the target pCO2 level. Number of sighs and NSFs 
decreased over time in both tests, but sighs were overall fewer and NSFs more during HV 
than HYPO. Fewer sighs during HYPO can be explained in two ways: first, as mentioned 
above, people are more likely to gasp for air when underbreathing, and second, the VT is 
much smaller and hence a smaller increase in air inhaled is required for a breath to be 
detected as a sigh. In addition, sighs showed a three-way interaction: they decreased 
during HV in the EA patients and NAC, but increased in the PD patients. The latter may 
have taken deeper breaths intermittently rather than evenly increasing their VT to keep 
their pCO2 low. Although breathing was paced, NAC had lower RR during the first 
minute of HV, which represented a failure to comply with instructions, and which 
appeared statistically as an interaction. During recovery from over- and underbreathing, 
only one primary and two secondary measures changed differently between groups. Tidal 
volume instability and sighs decreased more in PD than the other two groups, which 
made the group differences from baseline disappear. Respiration rate instability also 
showed an interaction, which was due to a very mild increase in the NAC but not in the 
patients.  
 
Often investigators have found respiratory abnormalities in PD compared to non-
anxious groups or other anxiety disorders at baseline and in response to respiratory 
challenges. However, published results are inconsistent in that some studies found 
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differences in both self-report and physiology, whereas in others PD was only different 
from other groups in self-report measures. We confirmed baseline respiratory 
abnormalities in PD by showing that they had higher RR, VTI, and number of sighs. The 
effects for VTI and sighs disappeared with the challenges. However, RR was higher 
during recovery than at baseline in the NAC and EA patients, which removed the Group 
differences that existed at baseline. Furthermore, PD patients were less active than the 
other two groups, which could have resulted in HR differences. However, this was not 
the case and hence we do not consider it likely that differences in activity level 
influenced any of our results. These data suggest that in terms of breathing frequency and 
HR, the challenges were more distressing to the NAC and EA patients.  
 
Unfortunately, there is little consensus on standards of a hyperventilation test, 
which makes comparisons between studies difficult. Studies vary greatly on variables 
such as breathing rate, target pCO2 level, duration of HV, and the use of pacing aids. 
Hornsveld et al. (Hornsveld, Garssen, & Spiegel, 1995) examined the influence of 
breathing depth and rate on symptom occurrence. According to them, a minimum of        
3 minutes and a pCO2 level below 1.9 kPA (14.3 mm Hg) is required for symptoms to 
appear in most people. On the other hand, Fried and Grimaldi (1993) reported that 
symptoms begin to emerge below 30 mm Hg. Since all of these factors appear to have 
independent influences on the outcome, one of them may have been insufficient in our 
study to elicit the effects often reported previously. Most studies that found differences 
between PD patients and other groups, had people hyperventilate down to at least          
20 mm Hg (Friedman, Mathis, Hayes, Renshaw, & Dager, 2006; Wilhelm, Gerlach, & 
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Roth, 2001; Maddock & Carter, 1991) or required a drop of 50% from baseline (Rapee, 
Brown, Antony, & Barlow, 1992). If no target pCO2 was given, usually a high RR was 
required (Han, Stegen, de Valck, Clement, & van de Woestijne, 1996; Nardi, Valenca, 
Nascimento, & Zin, 2001, 2002; Papp et al., 1997). Antony et al. (1997) did not find any 
differences between groups although a drop of 50% from baseline was required. 
However, people only hyperventilated for 90 seconds.  
 
Not all of our participants were able to lower their pCO2 to the target, which 
resulted in a mean pCO2 level of 22 mm Hg at the end of HV. In a recently submitted 
paper (Wollburg, Roth, Conrad, Meuret, & Kim, in press) we compared two levels of 
HV, 20 mm Hg and 25 mm Hg, and found differences in self-report only for the lower 
level and no differences in physiological measures at either target. However, our sample 
size was too small to exclude subjects who did not hyperventilate quite to 20 mm Hg. 
Moreover, participants did not reach their target until the last minute, which potentially 
reduced the actual duration of HV to as little as one minute. We would not interpret our 
negative findings in terms of the recovery from the challenges as evidence against 
existence of respiratory abnormalities in PD since differences under baseline conditions 
emerged. Hence, our data suggest either that the mean pCO2 level was too high and/or the 
duration of the HV too short. This also would explain why the anxiety ratings during the 
paced breathing and recovery were lower than in other studies (e.g., Maddock & Carter, 
1991; Rapee, Brown, Antony, & Barlow, 1992; Wilhelm, Gerlach, & Roth, 2001).  
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Hypoventilation on the other hand has been shown previously to be even more 
anxiety provoking than HV, but it usually was induced by inhalation of gas mixtures with 
higher than air CO2 concentrations. It is obvious that the increase in CO2 was much less 
in our study. However, as mentioned earlier, a criticism of those provocations is that they 
deliver unnaturally high CO2 levels, which renders conclusions from them questionable. 
We intended to produce a state that could possibly occur naturally outside the laboratory, 
but failed to replicate the previously reported differences. We had thought that prolonged 
hypoventilation even without much elevation in CO2, would be sufficient to bring out 
differences, which proved to be wrong.  
 
In the light of our results, we are unable to draw any conclusions about the state 
of the suffocation alarms of our second population, the EA patients. Perhaps at higher 
pCO2 levels both EA and PD patients would have reacted more than NAC. However, we 
did not find in EA patients the greater resting VTI, RR, or sighs that we observed in PD 
patients, which suggests, at least baseline respiratory abnormalities are specific to PD. 
 
It is unlikely that difference in clinical measures were the reason that we failed to 
find differences between groups in response to the challenges. The PD patients scored 
similarly higher on anxiety sensitivity than the other two groups, similar to previous 
studies of PD. As in other studies, patients with multiple diagnoses were not excluded. 
Generally, HV has been shown to be a rather mild panicogenic agent. Although unlikely, 
other cognitive factors could have contributed to our outcome: participants may have felt 
safe in the presence of an investigator and in addition, could have attributed symptoms to 
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an external event rather then to a spontaneous attack. For instance, Rapee (1990) and 
Barlow (1988, 1991) ascribed importance to the perception of lack of control during 
challenges, and Sanderson et al.’s study (Sanderson, Rapee, & Barlow, 1989) has shown 
how a perceived influence of control attenuates the reaction to CO2 inhalation. However, 
there is no reason to believe that patients felt safer in our laboratory than they would have 
in others.  
 
Another possible reason for inconsistency between studies is differences in the 
PD sample.  PD patients do not appear to be a homogeneous group, as evidenced by 
numerous studies that examined subgroups of PD and observed different reactions among 
those groups to biological challenges. One distinction that has often been made is 
between a respiratory and non-respiratory subtype of PD. Unfortunately, our sample size 
was too small to run valid analyses on such subgroups.  
 
No physiological measure showed Time x Group interactions during recovery that 
might have favored one or the other respiratory theories of PD. We expected that PD 
patients would react differently from controls to at least one of the challenges. Perhaps 
target levels were too low or high, respectively, in order to bring out these differences. 
Although resting pCO2 levels were not different between groups, PD patients’ greater 
VTI, RR, and sighs can be interpreted as consistent with the Suffocation False Alarm 
Theory as a way to keep the pCO2 safely below the threshold that could trigger a false 
alarm. On the other hand, PD patients did not feel less anxious during HV than HYPO. 
According to Klein, lower pCO2 should have made them feel more comfortable. 
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However, it should be noted that only a subgroup of subjects was included in the 
psychophysiological analyses, namely, those who complied with the instructions. As a 
result, 2 NAC, 13 PD, and 4 EA patients had to be excluded. Significantly more subjects 
from the PD group were unable to hypoventilate than people from the other two groups. 
This can also be seen as support for Klein’s theory since it is consistent with the idea that 
PD patients were reluctant to raise their pCO2 due to fear of triggering a false alarm and 
thus a panic attack. Our data support some of Ley’s assumptions as well: PD patients 
reacted more fearfully to HV than HYPO, and did not have higher panic rates than the 
other groups during HYPO. However, increase in anxiety was not different between 
groups and some patients did panic to HYPO.  
 
We were able to replicate some earlier findings of irregular breathing in PD 
patients. Results for the EA patient group confirm that these abnormalities are specific for 
a diagnosis of PD. However, we did not find the expected exaggerated response to 
respiratory challenges or a slower recovery from it that has been shown in previous 
studies. Psychological variables were tonically higher during all segments of the tests; 
physiological measures did not differ during the paced breathing and recovery periods 
between patients and controls. Unfortunately, we were unable to run follow-up analyses 
on subgroups of PD, such as respiratory vs. non-respiratory subtypes or panickers vs. 
non-panickers during the test, in order to examine alternative explanations. Findings 
suggest that hypo- and hyperventilation induced by alteration of one’s breathing are 
rather weak panicogenic agents. End-tidal pCO2 levels probably have to change more 
from baseline to bring out group differences.  
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Effects of Breathing Training 
 
We hypothesized that both treatment groups would show less psychological and 
physiological distress in response to the respiratory challenges after therapy. Since we 
failed to find an exaggerated response before treatment, only certain of our hypotheses 
could be tested. We confirmed that patients in the Raise condition had higher baseline 
pCO2 levels after than before treatment and hence, reached higher levels during HYPO 
than patients in the Lower condition, who had lowered resting pCO2 at post- compared to 
pre-treatment. Contrary to our hypothesis, patients given the Lower treatment also 
reached lower pCO2 levels during HV than those given the Raise treatment.  
 
Panic rates to the respiratory challenges did not change after successful treatment 
nor did the comparison of the two tests in terms of difficulty and discomfort. Overall, 
anxiety, tension, shortness of breath, and perceived heart racing were lower at the second 
assessment, but not differently between groups. Since these variables changed regardless 
of group assignment, they are most likely due to test-retest effects. Furthermore, the 
perception of feelings of shortness of breath and heart racing increased less from baseline 
to the paced breathing segments for both tests at follow-up compared to the initial 
assessment, also regardless of the group.  
 
For physiological measures, both treatments affected the breathing behavior at 
baseline: the Lower condition led to lower and Raise to higher resting pCO2 levels after 
treatment during all segments of the tests and in both PD and EA patients. Hence, 
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patients applied their breathing lessons outside their homework exercises. The absolute 
changes in pCO2 were not different between the two patient groups. Effect size 
differences for the resting pCO2 level between immediate treatment groups and wait-
listed patients were moderate (d >0.5) except for the comparison of EA Lower and EA 
WL, which was small (d >0.2). However, we did not see corresponding changes for RR 
or VT supposedly necessary to produce the lower or higher pCO2 levels. There was a 
trend for slower breathing rates at post-treatment, but it was not significant. Possibly with 
a bigger sample group differences would emerge. An explanation could be that people 
used different combinations of breathing rate and depth in order to produce the changes 
in CO2, which may have overwhelmed the overall effects. We did not find that the two 
treatments affected breathing in one way. Each had specific effects: both Lower groups 
were able to reach lower CO2 levels than the Raise groups, who on the other hand 
achieved higher levels during HYPO. This effect was not caused by different change 
rates within the tests but by baseline differences in pCO2. Surprisingly, the treatments did 
not affect other baseline breathing parameters although normalization of, for instance, 
breathing rate was also targeted in the homework exercises.  
 
The irregularities observed in PD at pre-treatment were not changed by therapy. 
However, during HYPO, the Lower condition had more sighs at post-treatment and the 
Raise condition fewer. The latter also had fewer sighs during recovery from HYPO. 
Since the patients in the hypercapnic group were accustomed to high pCO2 levels, they 
were perhaps less likely to feel a lack for air. However, this was not evidenced in 
different ratings of shortness of breath, which were lower at post-treatment in both tests.  
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In addition, baseline VT decreased from the first to the second assessment in all 
PD patients and the NAC, and increased in the EA patients. These changes were not 
related to treatment. However, we do not know why VT changed differently in the groups 
since at the beginning there were no differences. Furthermore, VT was overall lower at 
follow-up during the recovery periods, probably due to the overall lower VT in the NAC 
and PD groups.  
 
We also found a Group x Progress x Condition interaction for RRI during the 
paced breathing periods. Since all subjects were paced during these segments, we can 
only explain this result as non-compliance with the instructions at follow-up.  
 
Two of the three activation measures (HR, RSATF) were not affected by 
treatment, which was not surprising since respiratory measures and not heart rate or stress 
activation were targeted by the therapy. Furthermore, physical activity during the tests is 
expected to be the same at any given assessment time. Results for HR do not go along 
with the declined report of heart racing at follow-up. This is an example of the 
dissociation of self-report and physiology. Several studies have shown that especially the 
report of heart racing and actual HR correlate poorly (Alpers, Wilhelm, & Roth, 2005; 
Margraf, Taylor, Ehlers, Roth, & Agras, 1987; Wilhelm & Roth, 1998). Nevertheless, we 
cannot be sure that people overreported their heart sensations at the initial assessment or 
underreported them at follow-up, since these sensations probably depend more on pulse 
pressure, the difference between systolic and diastolic blood pressure, which gives a 
sensation of the heart pounding more than does a fast heart rate.  
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As expected, BT resulted in greater symptomatic improvement than waiting. At 
post-treatment, all immediate treatment groups were significantly better than the WL. 
Effect size differences between immediate and waitlisted patients for the main outcome 
measures were all large (p > 0.8). There were no differences between treatment 
conditions. Looking at the diagnoses at post-treatment, 56% no longer met full criteria for 
PD and 31% of the EA patients no longer met criteria for the diagnosis for which they 
were enrolled in the study. Agoraphobic avoidance did not change from pre- to          
post-treatment, which may be due to the high percentage of PD patients that did not 
suffer from Agoraphobia.  
 
Surprisingly, anxiety sensitivity changed equally in all groups from the first to the 
second assessment. Since effects for the PDSS were very large and comparable to our 
previous treatment study (Meuret, Wilhelm, Ritz, & Roth, in press), in which we used 
only the Raise condition, we also had expected the greater changes on the ASI in the 
immediate treatment groups compared to WL that we had seen previously. Nevertheless, 
although anxiety sensitivity improved in all groups, effects within the PD sample were 
large only for the immediate treatment groups and at a moderate level for the WL. For the 
EA patients, all groups showed large effects. However, ASI is only considered a measure 
of improvement in PD and hence, we would have not necessarily expected greater 
changes in the treated EA patients than EA WL.  
 
In terms of the main outcome measures, BT was equally effective for both PD and 
EA patients. Hence, there is reason to believe that any disorder with panic attacks would 
benefit from BT, regardless of not meeting full diagnostic criteria for PD or not having 
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had a history of PD. Although PD is characterized by experiencing panic attacks, 
treatment with BT should not be restricted to that disorder. Our data indicate that 
experiencing subclinical panic attacks may be sufficient for benefiting from BT even 
when those patients do not show the same baseline respiratory abnormalities as PD.  
 
Each treatment changed the patients’ resting pCO2 level in the direction 
prescribed by the particular therapy. From this it follows that there must have been 
mechanisms working that caused a positive treatment outcome other than mechanisms 
changing the tonic pCO2 level. Nevertheless, the treatment may have still had specific 
effects such as focusing attention on breathing. Furthermore, our results show that a 
general reduction in respiratory irregularity also cannot account for the outcome. The 
rationale of both therapies was that dysregulated breathing is central in PD and that 
learning better regulation will produce clinical improvement. Since both treatments 
worked equally well, we cannot say which respiratory theory of PD dysregulation is more 
valid. Perhaps subgroups of patients may benefit more from one or the other.  
 
In the light of our results, non-respiratory factors that were similar in both 
treatment groups are likely to have accounted for the clinical improvement. Aside from 
non-specific therapy effects such as the patient-therapist interaction, the direction of the 
patient’s attention to bodily sensations may have worked as interoceptive exposure and 
facilitated cognitive restructuring by desensitization and reattribution of bodily symptoms 
(Craske, Rowe, Lewin, & Noriega-Dimitri, 1997). In addition, the breathing exercises 
may have been perceived as a ‘tool’, a coping method, to employ in anxious situations, 
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which could have reduced the expectation of anxiety escalating into a panic attack. 
Patients may have either gained a sense of control over their anxiety attacks by being able 
to apply the learned breathing exercise or have used attention to breathing as distraction.  
 
We cannot rule out that the training worked because of non-respiratory factors. 
How can one ever disentangle pure cognitive components from BT?  It is hard to imagine 
that a successful BT would fail to change cognitions about panic. Reduction of attacks by 
any therapy must inevitably reduce catastrophic thinking. Evidence for a more respiratory 
mechanism might come from findings that a respiratory subtype would benefit more from 
BT than the non-respiratory one. We were unable to test this in these data, but Meuret et 
al. (Meuret, Wilhelm, Ritz, & Roth, in press) did find that a respiratory subtype did not 
benefit more from an anti-hyperventilatory therapy than did a non-respiratory subtype.  
 
Six PD and 4 EA patients dropped out before the second assessment, which 
resulted in slightly lower treatment effect estimates in the intention-to-treat analysis on 
some measures. However, this has little consequence for the validity of our results.  
Drop-outs did not differ on demographic or clinical measures. Differences on 
physiological measures did not indicate that completers were less severe in their reaction 
to the respiratory challenges and therefore were more likely to finish. Of course, we 
tested only a small number of drop-outs vs. a high proportion of completers. In addition, 
we assume that differences between the patient groups (Lower vs. Raise vs. WL) at     
pre-treatment had little effect on their comparability and on the validity of the outcome 
measures.   
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In summary, both the hypocapnic and hypercapnic treatments led to symptomatic 
improvement compared to waitlisted patients. As outlined above, we were unable to 
replicate previous findings in terms of the response to breathing challenges. However, 
from our results we can assert that benefits from BT accrue to those suffering from panic 
attacks (full-blown or subclinical) regardless of whether they meet full criteria for PD. 
The therapies changed tonic pCO2 level without effects on other respiratory or 
psychological measures during the laboratory assessment. This indicates that BT worked 
by variables other than the respiratory ones that had been targeted by the treatment. Our 
results imply that research on BT should not be restricted to PD, but expanded to other 
patients suffering from anxiety attacks.   
 
 
Methodological Limitations 
 
Several limitations apply to this study. There is always a chance that different 
statistical methods would have led to slightly different results. We chose the mixed-
effects models because it has advantages over conventional variance-analytic approaches, 
especially when analyzing psychophysiological data (Bagiella, Sloan, & Heitjan, 2000). 
First, one is able to specify variance-covariance matrices that best fit the data. Second, 
the mixed-effects models handle missing data more effectively by fitting them with 
maximum likelihood. However, each statistical approach has advantages and drawbacks. 
There is no perfect way to analyze such a multifaceted data set.  
 
 71
Psychophysiological Effects of Breathing Training in Panic Disorder and Episodic Anxiety  
 
An issue for this study is the nature of the EA patient group. Since we wanted to 
explore broadly whether patients suffering from anxiety attacks regardless of their 
primary diagnosis would show psychophysiological similarities to PD and benefit from 
BT, we collected what turned out to be a very heterogeneous EA group. Hence, we 
cannot rule out that this may have reduced certain effects found in pure PD patients and 
limited our inferences from the EA group. However, it is unlikely that the inclusion of 
comorbid anxiety disorders that have been shown to have exaggerated responses to 
respiratory challenges, such as SOP, overwhelmed effects of EA patients without them, 
since the majority of the EA group suffered from Anxiety NOS. Furthermore, increases 
and decreases in pCO2 during the challenges were insufficient to bring out group 
differences between NAC and PD which consequently limited a more detailed 
investigation of the EA patients. Using pCO2 targets relative to subjects’ baseline rather 
than absolute levels might have resulted in different findings.  
 
An additional general limitation is that the follow-up period was only 4 weeks. It 
is possible that treatment effects will wear off after a few months. 
 
 Since we included medicated participants, our psychophysiological data may have 
been somewhat compromised. We minimized pharmacological effects by only accepting 
patients who reported stable doses and by excluding cardiovascular and electrodermal 
data from patients saying that they took drugs with known effects on these systems. 
Nevertheless, we cannot be certain that all such effects were eliminated.  
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Our criterion for occurrence of a panic attack may have been too conservative, 
accounting for the lack of differences between groups. Often studies used a more 
complicated criterion to define panic attacks, such as experiencing at least four physical 
symptoms in addition to high anxiety (e.g., van den Hout, Marcel A., van der Molen, 
Griez, Lousberg, & Nansen, 1987). However, we took the standpoint of Holt & Andrews 
(1989b) that relying on the number of symptoms is misleading since physical sensations 
and anxiety during challenges are also experienced by non-anxious people. Ultimately, 
what is called a panic attacks is subjective.  
 
Finally, we need to point out that although overall we had a sufficient number of 
patients, when they were divided into 3 groups, numbers per treatment were fairly low. 
Sample sizes were reduced further for the psychophysiological analyses since we had to 
exclude subjects that did not comply with the instructions. There is reason to believe that 
a bigger sample may have resulted in more group differences. Furthermore, we were 
unable to conduct meaningful correlation analyses between the psychological and 
physiological measures due to the small sample sizes. 
 
 
Implications and Future Directions 
 
Our investigation of breathing abnormalities in PD and patients suffering from 
episodic anxiety attacks without a history of PD resulted in mixed findings. We replicated 
baseline abnormalities in PD but did not find an exaggerated response to voluntary hypo- 
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and hyperventilation compared to NAC. Episodic Anxiety patients showed abnormalities 
neither at baseline nor in reaction to the respiratory challenges. However, both patient 
groups benefited from the breathing therapies. Hypocapnic and hypercapnic treatment 
were equivalent in their outcome, which challenges the idea that a change of breathing 
was the main working mechanism. Improvement can rather be attributed to factors 
unrelated to the direct manipulation of pCO2. However, both treatment conditions were 
comparable on important variables such as duration of therapy, patient-therapist 
interaction, direction of attention to bodily sensations, and regularizing and slowing down 
breathing with use of a capnometer. Future trials of breathing therapies should be 
designed that keep the pCO2 level constant but manipulate other variables related and 
unrelated to breathing.  
 
In terms of laboratory tests, more work is needed to disentangle specific factors 
influencing the results such as duration of breathing manipulation, target pCO2 levels, 
breathing frequency, and the use of pacing aids. Furthermore, paused breathing may be 
more efficient in raising one’s CO2 than the method we taught patients. In another study, 
conducted at the same time as the one reported here, we found that healthy subjects were 
able to raise their pCO2 about 10 mm Hg by quick inhalation, paused breathing for         
18 seconds, and quick exhalation (Wollburg, Roth, & Kim, under review). This breathing 
pattern may be a better way to raise CO2 than, for example, gas mixtures, which have 
many psychological and physiological limitations.  
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Unfortunately, we were unable to run follow-up analyses on the subgroups of PD 
that have been suggested in the literature. Needless to say, it is important to know 
whether a respiratory subtype of PD would benefit more from the BT than other 
subtypes. In terms of our second patient group, the EA patients, future trials with more 
stringent inclusion criteria need to be run. Although unlikely to have influenced our 
results, patients with OCD should be evaluated as a separate group in future studies since 
they did not show respiratory abnormalities in past studies. Hence, they may dilute the 
common respiratory characteristics of other EA subgroups.  
 
Our short-term breathing therapies were effective in a substantial portion of 
patients. In the future, investigation of long-term outcome and direct comparison with 
standard CBT treatments would be useful to assess their clinical value more thoroughly. 
We hope that our breathing therapies will turn out to be long-term efficacious treatments 
for PD and other patients suffering from anxiety attacks, which may equal or surpass 
existing pharmacological and cognitive treatments. 
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